Enterococcus faecium DSM 17050 is a microaerophile bacterium that has multiple antibiotic resistances and was isolated from clinical sample.
antibiotic resistance microaerophile Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:26:08 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Enterococcaceae |
| Genus Enterococcus |
| Species Enterococcus faecium |
| Full scientific name Enterococcus faecium (Orla-Jensen 1919) Schleifer and Kilpper-Bälz 1984 |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 6710 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 6710 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 6710 | positive | growth | 37 |
| 6710 | Oxygen tolerancemicroaerophile |
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | Test 6 | |
|---|---|---|---|---|---|---|
| @ref | 6710 | 6710 | 6710 | 6710 | 6710 | 6710 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 12-14 | 16 | 0 | 14 | 14 | 18-20 |
| Ampicillin 10µg (disc) | 12 | 10 | 0 | 10 | 10 | 8 |
| Aztreonam 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Bacitracin 10Unit | 0 | 8 | 0 | 0 | 0 | n.d. |
| Cefalotin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | n.d. |
| Cefazolin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 0 |
| Cefotaxime 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 0 |
| Ceftriaxone 30µg (disc) | 0 | 0 | n.d. | 0 | 0 | 0 |
| Chloramphenicol 30µg (disc) | 26 | 24 | 0 | 22-24 | 22-24 | 26 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 24 |
| Clindamycin 10µg (disc) | 0 | 0 | n.d. | 0 | 0 | 0 |
| Colistin 10µg (disc) | 0 | 0 | 0 | 0 | 0 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 0 |
| Doxycycline 30µg (disc) | 20 | 18-20 | 12 | 16-18 | 16-18 | n.d. |
| Erythromycin 15µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Fosfomycin 50µg (disc) | 20 | 18-20 | n.d. | 18 | 18 | 16-18 |
| Gentamicin 10µg (disc) | 12 | 14-16 | 0 | 12 | 12 | n.d. |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 18 |
| Imipenem 10µg (disc) | 0 | 8 | 20 | 0 | 0 | 0 |
| Kanamycin 30µg (disc) | 10 | 22 | 0 | 10 | 10 | 12-14 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 22 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | 0 | 0 | n.d. |
| Linezolid 10µg (disc) | 32 | 28 | n.d. | 30 | 30 | 30 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 0 |
| Mezlocillin 30µg (disc) | 10-12 | 10 | 8 | 10 | 10 | n.d. |
| Moxifloxacin 5µg (disc) | 24-26 | 26 | n.d. | 22 | 22 | 26 |
| Neomycin 30µg (disc) | 14 | 14-16 | 10 | 14 | 14 | n.d. |
| Nitrofurantoin 100µg (disc) | 8-10 | 8 | 6 | 6-8 | 6-8 | 6 |
| Norfloxacin 10µg (disc) | 22 | 24 | 16 | 20 | 20 | n.d. |
| Nystatin 100Unit | 0 | 0 | n.d. | 0 | 0 | n.d. |
| Ofloxacin 5µg (disc) | 20 | 20 | 0 | 18 | 18 | 20 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 0 | 0 | 0 | 0 | 0 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 8 | 6 | n.d. | 6 | 6 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 0 |
| Polymyxin B 300Unit | 0 | 8 | 0 | 0 | 0 | 0 |
| Quinupristin/Dalfopristin 15µg (disc) | 18 | 20 | n.d. | 18 | 18 | 20 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 32-34 |
| Teicoplanin 30µg (disc) | 8 | 10 | n.d. | 8-10 | 8-10 | 6 |
| Tetracycline 30µg (disc) | 10-12 | 10-12 | 8 | 10 | 10 | 10 |
| Ticarcillin 75µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 28 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | 34 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 |
| 6710 | ObservationVancomycin resistant |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68381 | 29016 ChEBI | arginine | + | hydrolysis | from API rID32STR |
| 68381 | 18333 ChEBI | D-arabitol | - | builds acid from | from API rID32STR |
| 68381 | 16899 ChEBI | D-mannitol | + | builds acid from | from API rID32STR |
| 68381 | 16988 ChEBI | D-ribose | + | builds acid from | from API rID32STR |
| 68381 | 16443 ChEBI | D-tagatose | - | builds acid from | from API rID32STR |
| 68381 | 28087 ChEBI | glycogen | - | builds acid from | from API rID32STR |
| 68381 | 30849 ChEBI | L-arabinose | + | builds acid from | from API rID32STR |
| 68381 | 17716 ChEBI | lactose | + | builds acid from | from API rID32STR |
| 68381 | 17306 ChEBI | maltose | + | builds acid from | from API rID32STR |
| 68381 | 6731 ChEBI | melezitose | - | builds acid from | from API rID32STR |
| 68381 | 320055 ChEBI | methyl beta-D-glucopyranoside | + | builds acid from | from API rID32STR |
| 68381 | 27941 ChEBI | pullulan | - | builds acid from | from API rID32STR |
| 68381 | 30911 ChEBI | sorbitol | - | builds acid from | from API rID32STR |
| 68381 | 17992 ChEBI | sucrose | - | builds acid from | from API rID32STR |
| 68381 | 27082 ChEBI | trehalose | + | builds acid from | from API rID32STR |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 6710 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 6710 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 6710 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 6710 | 140376 | Cefiderocol | 30 µg (disc) | from Antibiotic test | |
| 6710 | 204928 | Cefotaxime | 30 µg (disc) | from Antibiotic test | |
| 6710 | 3508 | Ceftazidime | 10 µg (disc) | from Antibiotic test | |
| 6710 | 29007 | Ceftriaxone | 30 µg (disc) | from Antibiotic test | |
| 6710 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 6710 | 37943 | Colistin | 10 µg (disc) | from Antibiotic test | |
| 6710 | 37943 | Colistin sulphate | 10 µg (disc) | from Antibiotic test | |
| 6710 | 48923 | Erythromycin | 15 µg (disc) | from Antibiotic test | |
| 6710 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 6710 | 43968 | Meropenem | 10 µg (disc) | from Antibiotic test | |
| 6710 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 6710 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 6710 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 6710 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 6710 | Piperacillin/Tazobactam | 110 µg (disc) | from Antibiotic test | ||
| 6710 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 6710 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | from API rID32STR |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | + | from API rID32STR |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68381 | Alanyl-Phenylalanyl-Proline arylamidase | - | from API rID32STR | |
| 68381 | alkaline phosphatase | - | 3.1.3.1 | from API rID32STR |
| 68381 | arginine dihydrolase | + | 3.5.3.6 | from API rID32STR |
| 68381 | beta-galactosidase | + | 3.2.1.23 | from API rID32STR |
| 68381 | beta-glucosidase | + | 3.2.1.21 | from API rID32STR |
| 68381 | beta-glucuronidase | - | 3.2.1.31 | from API rID32STR |
| 6710 | catalase | - | 1.11.1.6 | |
| 6710 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68381 | pyrrolidonyl arylamidase | + | 3.4.19.3 | from API rID32STR |
| @ref | ADH (Arg) | beta GLU | beta GAR | beta GUR | alpha GAL | PAL | RIB | MAN | SOR | LAC | TRE | RAF | SAC | LARA | DARL | Acid from alpha-cyclodextrinCDEX | Acetoin production (Voges Proskauer test)VP | Alanyl-Phenylalanyl-Proline arylamidaseAPPA | beta GAL | Pyrrolidonyl arylamidasePyrA | N-Acetyl-glucosaminidasebeta NAG | Glycyl-tryptophan arylamidaseGTA | HIP | GLYG | PUL | MAL | MEL | MLZ | Acidification of methyl beta-D-glucopyranosideMbeta DG | TAG | beta MAN | URE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6710 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | - | - | - | + | - | - | + | - | - | - | |
| 6710 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | + | - | - | + | - | - | + | - | - | - | |
| 6710 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | - | + | - | + | + | - | - | - | - | - | + | - | - | + | - | - | + | |
| 6710 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | - | - | - | - | - | + | - | - | + | - | + | - | |
| 6710 | + | + | - | - | +/- | - | + | + | - | + | + | + | - | + | - | + | + | - | + | + | - | - | - | - | - | + | + | - | + | - | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Synthetic studies on the tetrasubstituted D-ring of cystobactamids lead to potent terephthalic acid antibiotics. | Stappert M, Kohnhauser D, Seedorf T, Coetzee J, Rox K, Fuchs HLS, Cirnski K, Leitner C, Herrmann J, Kirschning A, Muller R, Bronstrup M. | Commun Chem | 10.1038/s42004-024-01337-6 | 2024 | | |
| The Kinocidin Interleukin-26 Shows Immediate Antimicrobial Effects Even to Multi-resistant Isolates. | Hansen BT, Maschkowitz G, Podschun R, Fickenscher H. | Front Microbiol | 10.3389/fmicb.2021.757215 | 2021 | | |
| Characterization of the salivary microbiome before and after antibiotic therapy via separation technique. | Pauter-Iwicka K, Railean V, Zloch M, Pomastowski P, Szultka-Mlynska M, Blonska D, Kupczyk W, Buszewski B. | Appl Microbiol Biotechnol | 10.1007/s00253-023-12371-0 | 2023 | | |
| The bacteriocin Angicin interferes with bacterial membrane integrity through interaction with the mannose phosphotransferase system. | Vogel V, Olari LR, Jachmann M, Reich SJ, Haring M, Kissmann AK, Rosenau F, Riedel CU, Munch J, Spellerberg B. | Front Microbiol | 10.3389/fmicb.2022.991145 | 2022 | | |
| Enzymology | Regio- and Stereoselective Epoxidation and Acidic Epoxide Opening of Antibacterial and Antiplasmodial Chlorotonils Yield Highly Potent Derivatives. | Hofer W, Oueis E, Fayad AA, Deschner F, Andreas A, de Carvalho LP, Huttel S, Bernecker S, Patzold L, Morgenstern B, Zaburannyi N, Bischoff M, Stadler M, Held J, Herrmann J, Muller R. | Angew Chem Int Ed Engl | 10.1002/anie.202202816 | 2022 | |
| Pathogenicity | Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains. | Gonzalez-Garcia M, Morales-Vicente F, Pico ED, Garay H, Rivera DG, Grieshober M, Raluca Olari L, Gross R, Conzelmann C, Kruger F, Zech F, Prelli Bozzo C, Muller JA, Zelikin A, Raber H, Kubiczek D, Rosenau F, Munch J, Stenger S, Spellerberg B, Franco OL, Rodriguez Alfonso AA, Standker L, Otero-Gonzalez AJ. | Biomolecules | 10.3390/biom11050745 | 2021 | |
| Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms. | Hoenes K, Bauer R, Meurle T, Spellerberg B, Hessling M. | Front Microbiol | 10.3389/fmicb.2020.612367 | 2020 | | |
| Broad Spectrum Antibiotic Xanthocillin X Effectively Kills Acinetobacter baumannii via Dysregulation of Heme Biosynthesis. | Hubner I, Shapiro JA, Hossmann J, Drechsel J, Hacker SM, Rather PN, Pieper DH, Wuest WM, Sieber SA. | ACS Cent Sci | 10.1021/acscentsci.0c01621 | 2021 | | |
| Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria. | Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. | Microorganisms | 10.3390/microorganisms8050626 | 2020 | | |
| Cultivation | LBJMR medium: a new polyvalent culture medium for isolating and selecting vancomycin and colistin-resistant bacteria. | Bardet L, Le Page S, Leangapichart T, Rolain JM. | BMC Microbiol | 10.1186/s12866-017-1128-x | 2017 | |
| Pathogenicity | Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures. | Wellinghausen N, Pietzcker T, Poppert S, Belak S, Fieser N, Bartel M, Essig A. | J Clin Microbiol | 10.1128/jcm.01856-06 | 2007 | |
| Metabolism | Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2. | Preisitsch M, Heiden SE, Beerbaum M, Niedermeyer TH, Schneefeld M, Herrmann J, Kumpfmuller J, Thurmer A, Neidhardt I, Wiesner C, Daniel R, Muller R, Bange FC, Schmieder P, Schweder T, Mundt S. | Mar Drugs | 10.3390/md14010021 | 2016 | |
| Enzymology | Quantitative PCR monitoring of antibiotic resistance genes and bacterial pathogens in three European artificial groundwater recharge systems. | Bockelmann U, Dorries HH, Ayuso-Gabella MN, Salgot de Marcay M, Tandoi V, Levantesi C, Masciopinto C, Van Houtte E, Szewzyk U, Wintgens T, Grohmann E. | Appl Environ Microbiol | 10.1128/aem.01649-08 | 2009 | |
| Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024. | Vuichard-Gysin D, Buchler AC, Blanc DS, Keller PM, Schlapfer P, Kronenberg A, Piezzi V, Nordmann P, Senn L, Harbarth S, Tschudin-Sutter S. | Euro Surveill | 10.2807/1560-7917.es.2025.30.45.2500227 | 2025 | | |
| Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study. | Del Monte M, Kaleci S, Chester J, Zerbato V, Remitti M, Tili A, Dessilani A, Baldisserotto I, Esperti S, Di Trapani MD, Orlando G, Casolari S, Catania A, Bedini A, Franceschini E, Sarti M, Venturelli C, Venturelli I, Rofrano L, Ricchizzi E, Di Bella S, Mussini C, Meschiari M. | J Antimicrob Chemother | 10.1093/jac/dkaf242 | 2025 | | |
| Bimetallic nanoparticles synthesized from Korean red ginseng (Panax ginseng) root extract as nanocatalysts and in vitro antibacterial activity of Au-Ag alloy. | Lee G, Park Y. | Discov Nano | 10.1186/s11671-025-04313-8 | 2025 | | |
| Simultaneous inactivation of antibiotic-resistant bacteria and degradation of antibiotic-resistant genes in alkalised human urine. | Demissie N, Nordin A, Simha P, Conroy I, Sun H, Schnurer A, Vinneras B, Desta A. | Front Microbiol | 10.3389/fmicb.2025.1605625 | 2025 | | |
| Genetics | Characterization of vanA-harboring plasmids supports differentiation of outbreak-related and sporadic vancomycin-resistant Enterococcus faecium isolates in a tertiary care hospital. | Sobkowiak A, Scherff N, van Almsick V, Schuler F, Brix TJ, Mellmann A, Schwierzeck V. | BMC Microbiol | 10.1186/s12866-025-04058-5 | 2025 | |
| A nano-enabled adjunctive therapy to prevent vancomycin resistance evolution: Toward nano-anti-antibiotics. | Koshani R, Yeh SL, Vom Steeg LG, Pitcher ML, Kirigo J, Leconey S, He Z, Park MJ, Woods RJ, Read AF, Sheikhi A. | Biomaterials | 10.1016/j.biomaterials.2025.123141 | 2025 | | |
| Prevalence of Enterococcus Species in Various Clinical Samples and Their Antimicrobial Susceptibility Pattern. | Mahajan M, Shinde R, Karande GS, Patil S. | Cureus | 10.7759/cureus.72836 | 2024 | | |
| Multidrug-Resistant Elizabethkingia meningoseptica and Enterococcus faecium Infection in an Oncohematologic Patient. | Ferreira CM, Barbosa MNS, Ferreira GMA, Cristino JS, Alves CDS, Vieira EDS, Gomes LA, Souza VS, Calheiros FO, Ferreira WA. | Am J Case Rep | 10.12659/ajcr.945360 | 2024 | | |
| Genetics | Pheno- and Genotypic Epidemiological Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Intensive Care Unit Patients in Central Türkiye. | Akineden A, CiCek C, TUrkel S, Khan IUH, Abdulmawjood A. | Pol J Microbiol | 10.33073/pjm-2024-030 | 2024 | |
| Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China. | Pan P, Sun L, Shi X, Huang X, Yin Y, Pan B, Hu L, Shen Q. | BMC Med Genomics | 10.1186/s12920-024-01948-x | 2024 | | |
| Evaluation of the Diagnostic Accuracy of the T2Resistance Panel (Research Use Only) in Patients With Possible Bacterial Bloodstream Infections. | Ashcraft D, Pierre JS, Davis H, Scariano S, Latsis M, Vortisch R, Smith S, Pankey G. | Ochsner J | 10.31486/toj.24.0101 | 2025 | | |
| Effect of biofire blood culture identification 2 (BCID2) panel versus a matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) rapid incubation protocol on time to optimal therapy in patients with positive blood cultures. | Baum A, Miller JL, Gavaghan V, Beck ET, Argotsinger J. | BMC Infect Dis | 10.1186/s12879-025-11354-y | 2025 | | |
| Rapid and accurate sepsis diagnostics via a novel probe-based multiplex real-time PCR system. | Favaro M, Fini C, Capannari M, Petriccione I, Rotondo C, Navarra A, Stellitano C, De Giuli C, Vulcano A, Fontana C. | Microbiol Spectr | 10.1128/spectrum.00559-25 | 2025 | | |
| Genetics | A Study on Glycopeptide-Resistant Genotypes among Clinical Isolates of Enterococcus with Van B Phenotype. | Rajan R. | Adv Biomed Res | 10.4103/abr.abr_133_21 | 2023 | |
| Genetics | Surveillance and Characterization of Vancomycin-Resistant and Vancomycin-Variable Enterococci in a Hospital Setting | Rotondo C, Antonelli V, Rossi A, D'Arezzo S, Selleri M, Properzi M, Turco S, Chillemi G, Dimartino V, Venditti C, Guerci S, Galli P, Nisii C, Arcangeli A, Caraffa E, Cicalini S, Fontana C. | Antibiotics (Basel) | 2025 | | |
| Antimicrobial Resistance in ESKAPE Pathogens: A Retrospective Epidemiological Study at the University Hospital of Palermo, Italy. | Pipito L, Rubino R, D'Agati G, Bono E, Mazzola CV, Urso S, Zinna G, Distefano SA, Firenze A, Bonura C, Giammanco GM, Cascio A. | Antibiotics (Basel) | 10.3390/antibiotics14020186 | 2025 | | |
| Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit. | Stoian M, Azamfirei L, Andone A, Vasiesiu AM, Stingaciu A, Hutanu A, Bandila SR, Dobru D, Manea A, Stoian A. | Biomedicines | 10.3390/biomedicines13061333 | 2025 | | |
| Genetics | An Outbreak of Vancomycin-Resistant Enterococci in a City Hospital Intensive Care Unit: Molecular Characterization of Resistance. | Senol FF, Tanriverdi ES, Aytac O, Asci Toraman Z, Otlu B. | Medicina (Kaunas) | 10.3390/medicina59122081 | 2023 | |
| Enterococcus isolated from poultry intestine for potential probiotic use. | Carvajal E, Contreras S, Diaz W, Martinez-Bello D, McCown M, Ardila Y, Vasquez MC. | Vet World | 10.14202/vetworld.2023.1605-1614 | 2023 | | |
| Vancomycin-resistant Enterococcus (VRE) isolates from dogs and cats in veterinary hospitals in Brazil. | Sfaciotte RAP, Parussolo L, Melo FD, Schneider MF, da Costa UM, Schwarz DGG, Salbego FZ, Ferraz SM. | BMC Vet Res | 10.1186/s12917-025-04557-7 | 2025 | | |
| Seasonal prevalence and antimicrobial resistance profiles in Enterococcus spp. identified from mussels farmed along the coasts of the Abruzzo region. | Ferri G, Olivieri V, Di Vittori C, Vergara A. | Ital J Food Saf | 10.4081/ijfs.2025.13563 | 2025 | | |
| Study on cerebrospinal fluid meropenem, vancomycin and tigecycline monitoring in patients with central nervous system infection following neurosurgery under different drug regimens. | Zhao X, Qiao Y, Xie Q, Zhang Z, Song Y, Kang J, Li J, Duan J. | Front Pharmacol | 10.3389/fphar.2025.1666168 | 2025 | | |
| The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019-2022). | Getahun Strobel A, Prasad P, Prasad V, Naidu R, Young-Sharma T, Suka A, Richards M, Cameron D, Lane CR, Buising K, Howden BP, Autar S. | J Glob Antimicrob Resist | 10.1016/j.jgar.2024.03.008 | 2024 | | |
| High Mortality and Antimicrobial Resistance: Challenges of Bloodstream Infections in Liver Transplant Recipients. | Brescini L, Signorino GG, Montalti R, Pallotta F, Morroni G, Nicolini D, Mocchegiani F, Vivarelli M, Svegliati-Baroni G, Tavio M, Cerutti E, Giacometti A, Barchiesi F. | Infez Med | 10.53854/liim-3302-6 | 2025 | | |
| The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document. | Candel FJ, Salavert M, Canton R, Del Pozo JL, Galan-Sanchez F, Navarro D, Rodriguez A, Rodriguez JC, Rodriguez-Aguirregabiria M, Suberviola B, Zaragoza R. | Crit Care | 10.1186/s13054-024-05224-3 | 2024 | | |
| Virulence gene detection and antimicrobial resistance analysis of Enterococcus faecium in captive giant pandas (Ailuropoda melanoleuca) in China. | Liu HF, Huang XY, Li ZM, Zhou ZY, Zhong ZJ, Peng GN. | Acta Vet Scand | 10.1186/s13028-023-00668-z | 2023 | | |
| Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India. | Sengupta M, Sarkar R, Sarkar S, Sengupta M, Ghosh S, Banerjee P. | Diagnostics (Basel) | 10.3390/diagnostics13050945 | 2023 | | |
| Polymeric Anti-Antibiotic Microparticles to Prevent Antibiotic Resistance Evolution. | Koshani R, Yeh SL, He Z, Narasimhalu N, Vom Steeg LG, Sim DG, Woods RJ, Read AF, Sheikhi A. | Small | 10.1002/smll.202407549 | 2025 | | |
| Enterococcal infections in a tertiary care hospital, North India. | Yadav RK, Agarwal L. | Ann Afr Med | 10.4103/aam.aam_110_20 | 2022 | | |
| Molecular detection and occurrence of vancomycin resistance genes (van A, B, C1, C2/C3) among Enterococcus species isolated from farm ostriches. | Mirzaie S, Faghiri I, Askari Badouei M, Madani SA. | Vet Med Sci | 10.1002/vms3.1010 | 2023 | | |
| Genetics | Genome analysis of multidrug resistant Enterococcus faecium and Enterococcus faecalis circulating among hospitalized patients in uMgungundlovu District, KwaZulu-Natal, South Africa. | Founou RC, Founou LL, Allam M, Ismail A, Essack SY. | BMC Infect Dis | 10.1186/s12879-024-09380-3 | 2024 | |
| Vancomycin-resistant Enterococcus infections in a hospital in Salvador, Bahia: a descriptive study, 2021-2023. | Rocha VF, Barbosa MS, Neves EDS, Santos VJ, Rego RFDS, Pessoa TL, Ribeiro MT, Santos JLAD, Pereira FM, Reis JN. | Epidemiol Serv Saude | 10.1590/s2237-96222024v34e20240135.en | 2025 | | |
| Distribution and Antibiotic Resistance Analysis of 13,048 Clinically Common Isolates. | Zhao J, Yue P, Li ZJ, Xu T, Xing GZ, Shao Y, Yu HY. | Infect Drug Resist | 10.2147/idr.s510193 | 2025 | | |
| Descriptive Analysis of Circulating Antimicrobial Resistance Genes in Vancomycin-Resistant Enterococcus (VRE) during the COVID-19 Pandemic. | Toc DA, Butiuc-Keul AL, Iordache D, Botan A, Mihaila RM, Costache CA, Colosi IA, Chiorean C, Neagoe DS, Gheorghiu L, Junie LM. | Biomedicines | 10.3390/biomedicines10051122 | 2022 | | |
| Foodborne Microbial Communities as Potential Reservoirs of Antimicrobial Resistance Genes for Pathogens: A Critical Review of the Recent Literature. | Zinno P, Perozzi G, Devirgiliis C. | Microorganisms | 10.3390/microorganisms11071696 | 2023 | | |
| Safety and metabolic characteristics of 17 Enterococcus faecium isolates. | Yuksekdag Z, Ahlatci NS, Hajikhani R, Darilmaz DO, Beyatli Y. | Arch Microbiol | 10.1007/s00203-021-02536-8 | 2021 | | |
| Determination of the Prevalence and Antimicrobial Resistance of Enterococcus faecalis and Enterococcus faecium Associated with Poultry in Four Districts in Zambia. | Mwikuma G, Kainga H, Kallu SA, Nakajima C, Suzuki Y, Hang'ombe BM. | Antibiotics (Basel) | 10.3390/antibiotics12040657 | 2023 | | |
| Tolerance of clinical vancomycin-resistant Enterococcus faecium isolates against UV-C light from a mobile source. | Knobling B, Franke G, Belmar Campos C, Buttner H, Christner M, Klupp EM, Maurer PM, Knobloch JK. | Antimicrob Resist Infect Control | 10.1186/s13756-023-01259-3 | 2023 | | |
| Genetics | Sequence type 17 is a predictor of subsequent bacteremia in vancomycin-resistant Enterococcus faecium-colonized patients: a retrospective cohort study. | Kim SH, Cho SY, Kim HM, Huh K, Kang CI, Peck KR, Chung DR. | Antimicrob Resist Infect Control | 10.1186/s13756-021-00980-1 | 2021 | |
| Enterococci, Van Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany. | Geissler M, Schrottner P, Oertel R, Dumke R. | Microorganisms | 10.3390/microorganisms12010149 | 2024 | | |
| High-level gentamicin resistance mediated by Aac(6')-Ie-aph(2")-Ia gene in Enterococcus species isolated from clinical samples in Northern India. | Das AK, Dudeja M, Kohli S, Ray P, Nandy S. | Indian J Pharmacol | 10.4103/ijp.ijp_41_20 | 2022 | | |
| Genetics | Phenotypic and genotypic characteristics of mecA - positive oxacillin-sensitive Staphylococcus aureus isolated from patients with bloodstream infection in a tertiary hospital in Southern Brazil. | Duarte FC, Olak APS, Cardim SL, Danelli T, Magalhaes GLG, Oliveira DML, Pimenta JDS, Vespero EC, Yamada-Ogatta SF, Perugini MRE. | Braz J Microbiol | 10.1007/s42770-024-01420-z | 2024 | |
| Metabolism | Intestinal carriage of vancomycin-resistant Enterococcus spp. among high-risk patients in university hospitals in Serbia: first surveillance report. | Janjusevic A, Markovic Denic L, Minic R, Grgurevic A, Cirkovic I. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-021-00423-0 | 2021 | |
| Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients. | Rafey A, Nizamuddin S, Qureshi W, Anjum A, Parveen A. | Cureus | 10.7759/cureus.31335 | 2022 | | |
| Probiotic potential and safety assessment of bacteriocinogenic Enterococcus faecium strains with antibacterial activity against Listeria and vancomycin-resistant enterococci. | Fugaban JII, Holzapfel WH, Todorov SD. | Curr Res Microb Sci | 10.1016/j.crmicr.2021.100070 | 2021 | | |
| Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens. | Squitieri D, Massaro F, Graziano MM, Borocci S, Cacaci M, Di Vito M, Porcelli F, Rosato R, Ceccacci F, Sanguinetti M, Buonocore F, Bugli F. | Front Microbiol | 10.3389/fmicb.2024.1447301 | 2024 | | |
| Biofilm Producing Enterococcus Isolates from Vaginal Microbiota. | Sengupta M, Sarkar S, SenGupta M, Ghosh S, Sarkar R, Banerjee P. | Antibiotics (Basel) | 10.3390/antibiotics10091082 | 2021 | | |
| Rapid Detection of Pathogens and Resistance Genes Grown in Blood Cultures with Two Multiplex Tandem Real-Time PCR Kits. | Gulhan B, Cikman A, Aydin M, Hasbek M, Ozekinci T, Akyuz S, Karakecili F. | Infect Dis Clin Microbiol | 10.36519/idcm.2025.465 | 2025 | | |
| Safety Evaluation, Biogenic Amine Formation, and Enzymatic Activity Profiles of Autochthonous Enterocin-Producing Greek Cheese Isolates of the Enterococcus faecium/durans Group. | Tsanasidou C, Asimakoula S, Sameli N, Fanitsios C, Vandera E, Bosnea L, Koukkou AI, Samelis J. | Microorganisms | 10.3390/microorganisms9040777 | 2021 | | |
| Evaluation of sample pooling using Xpert Carba-R and Xpert vanA/vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization. | Keidar-Friedman D, Gil L, Tsur A, Brosh-Nissimov T, Carmeli Y, Rosenfeld BD, Sorek N. | Microbiol Spectr | 10.1128/spectrum.01080-25 | 2025 | | |
| Vancomycin-Resistant Enterococcus Endocarditis Complicated by Splenic Infarction and Embolic Stroke. | Khatri S, Teferi A, Kashfi S, Chamay S, Sharma S. | Cureus | 10.7759/cureus.40633 | 2023 | | |
| Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments. | Lupia T, De Benedetto I, Bosio R, Shbaklo N, De Rosa FG, Corcione S. | Life (Basel) | 10.3390/life13040959 | 2023 | | |
| Risk Factors for Acute Cholangitis Caused by Enterococcus faecalis and Enterococcus faecium. | Karasawa Y, Kato J, Kawamura S, Kojima K, Ohki T, Seki M, Tagawa K, Toda N. | Gut Liver | 10.5009/gnl20214 | 2021 | | |
| Potential value of a rapid syndromic multiplex PCR for the diagnosis of native and prosthetic joint infections: a real-world evidence study. | Pascual S, Noble B, Ahmad-Saeed N, Aldridge C, Ambretti S, Amit S, Annett R, O'Shea SA, Barbui AM, Barlow G, Barrett L, Berth M, Bondi A, Boran N, Boyd SE, Chaves C, Clauss M, Davies P, Dianzo-Delgado IT, Esteban J, Fuchs S, Friis-Hansen L, Goldenberger D, Golle A, Groonroos JO, Hoffmann I, Hoffmann T, Hughes H, Ivanova M, Jezek P, Jones G, Ceren Karahan Z, Lass-Florl C, Laurent F, Leach L, Horsboll Pedersen ML, Loiez C, Lynch M, Maloney RJ, Marsh M, Milburn O, Mitchell S, Moore LSP, Moffat L, Murdjeva M, Murphy ME, Nayar D, Nigrisoli G, O'Sullivan F, Oz B, Peach T, Petridou C, Prinz M, Rak M, Reidy N, Rossolini GM, Roux AL, Ruiz-Garbajosa P, Saeed K, Salar-Vidal L, Salas Venero C, Selvaratnam M, Senneville E, Starzengruber P, Talbot B, Taylor V, Trebse R, Wearmouth D, Willinger B, Wouthuyzen-Bakker M, Couturier B, Allantaz F. | J Bone Jt Infect | 10.5194/jbji-9-87-2024 | 2024 | | |
| [Changes and Trends of Drug Resistance of Pathogenic Bacteria in Blood Samples of a Tertiary-Level Teaching Hospital from 2016 to 2020]. | Deng J, Kang M, Xie Y, Ma Y. | Sichuan Da Xue Xue Bao Yi Xue Ban | 10.12182/20220760506 | 2022 | | |
| Rabbit carcasses as important vectors of multidrug-resistant Enterococcus faecalis, but not E. faecium: prevalence and molecular characterization from a study in Poland | Knysz P, Szkucik K, Gondek M. | BMC Vet Res | 2025 | | ||
| Correlation between the results of cultures and the molecular BIOFIRE® joint infection panel in a cohort of pediatric patients with bone and joint infections in Bogotá, Colombia. | Camacho-Moreno G, Vergara-Amador E, Martinez-Villegas T, Aragon-Joya Y, Romero-Cardozo L, Lores-Garcia F, Moreno VM, Leal-Castro AL. | Front Pediatr | 10.3389/fped.2024.1359736 | 2024 | | |
| Pathogenicity | Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature. | Li F, Wang Y, Sun L, Wang X. | BMC Infect Dis | 10.1186/s12879-020-4892-4 | 2020 | |
| Pathogenicity | Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia. | Kirkizlar TA, Akalin H, Kirkizlar O, Ozkalemkas F, Ozkocaman V, Kazak E, Ozakin C, Bulbul EN, Ozboz ES, Ali R. | Leuk Res | 10.1016/j.leukres.2020.106463 | 2020 | |
| Prevalence of antibiotic resistance in lactic acid bacteria isolated from traditional fermented Indian food products. | Ojha AK, Shah NP, Mishra V, Emanuel N, Taneja NK. | Food Sci Biotechnol | 10.1007/s10068-023-01305-1 | 2023 | | |
| Wastewater treatment plants, an "escape gate" for ESCAPE pathogens. | Marutescu LG, Popa M, Gheorghe-Barbu I, Barbu IC, Rodriguez-Molina D, Berglund F, Blaak H, Flach CF, Kemper MA, Spiessberger B, Wengenroth L, Larsson DGJ, Nowak D, Radon K, de Roda Husman AM, Wieser A, Schmitt H, Pircalabioru Gradisteanu G, Vrancianu CO, Chifiriuc MC. | Front Microbiol | 10.3389/fmicb.2023.1193907 | 2023 | | |
| Antimicrobial Resistance in Bacteria from Meat and Meat Products: A One Health Perspective. | Conceicao S, Queiroga MC, Laranjo M. | Microorganisms | 10.3390/microorganisms11102581 | 2023 | | |
| Vancomycin-resistant Staphylococcus aureus endangers Egyptian dairy herds. | Tartor YH, Enany ME, Ismail NI, El-Demerdash AS, Eidaroos NH, Algendy RM, Mahmmod Y, Elsohaby I. | Sci Rep | 10.1038/s41598-024-81516-6 | 2024 | | |
| Molecular characterization of resistance and biofilm genes of ESKAPE pathogens isolated from clinical samples: examination of the effect of boric acid on biofilm ability by cell culture method. | Celebi O, Baser S, Guler MC, Taghizadehghalehjoughi A, Rakici E, Aydin E, Celebi D. | BMC Microbiol | 10.1186/s12866-025-03830-x | 2025 | | |
| Characterisation of in vitro resistance selection against second-/last-line antibiotics in methicillin-resistant Staphylococcus aureus ATCC 43300 strain. | Prasetyoputri A, Pitt ME, Cao MD, Ramu S, Kavanagh A, Elliott AG, Ganesamoorthy D, Monk IR, Stinear TP, Cooper MA, Coin LJM, Blaskovich MAT. | JAC Antimicrob Resist | 10.1093/jacamr/dlaf108 | 2025 | | |
| Long-Lasting Decrease of the Acquisition of Enterococcus faecium and Gram-Negative Bacteria Producing Extended Spectrum Beta-Lactamase (ESBL) by Transient Application of Probiotics. | Borgmann S, Riess B, Meintrup D, Klare I, Werner G. | Int J Environ Res Public Health | 10.3390/ijerph17176100 | 2020 | | |
| Insight into the Antibacterial Action of Iodinated Imine, an Analogue of Rafoxanide: a Comprehensive Study of Its Antistaphylococcal Activity. | Kratky M, Konecna K, Jandourek O, Diepoltova A, Vavrova P, Voxova B, Vejsova M, Barta P, Bosze S. | Microbiol Spectr | 10.1128/spectrum.03064-22 | 2023 | | |
| Impact of Adding a Rapid PCR-Based Blood Culture Identification Panel to the Antimicrobial Stewardship Program of Patients with Febrile Neutropenia in a Peruvian Referral Hospital. | Perez-Lazo G, Del Valle-Mendoza J, Sandoval-Ahumada R, Soto-Febres F, Castillo-Cordova R, Zarate-Tantalean M, Morales-Castillo L, Paucar-Miranda CJ, Altamirano-Molina M, Pacheco-Modesto I, Ruiz de Somocurcio-Cruzado C, Arana-Jurado D, Del Villar-Alarcon C, Vargas-Castro O, Diaz-Bardales C, Guerrero-Arismendiz B, Eyzaguirre-Zapata R, Aguilar-Luis MA, Martins-Luna J, Silva-Caso W. | Antibiotics (Basel) | 10.3390/antibiotics12040648 | 2023 | | |
| Genetics | Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis. | Sherry NL, Gorrie CL, Kwong JC, Higgs C, Stuart RL, Marshall C, Ballard SA, Sait M, Korman TM, Slavin MA, Lee RS, Graham M, Leroi M, Worth LJ, Chan HT, Seemann T, Grayson ML, Howden BP, Controlling Superbugs Study Group. | Lancet Reg Health West Pac | 10.1016/j.lanwpc.2022.100446 | 2022 | |
| Analysis of Antibiotic-Resistant and Virulence Genes of Enterococcus Detected in Calf Colostrum-One Health Perspective. | Cunha S, Miranda C, Martins A, Soares R, Maia M, Silva F, Igrejas G, Poeta P. | Animals (Basel) | 10.3390/ani13121900 | 2023 | | |
| Pathogenicity | Enterococcus faecium: from microbiological insights to practical recommendations for infection control and diagnostics. | Zhou X, Willems RJL, Friedrich AW, Rossen JWA, Bathoorn E. | Antimicrob Resist Infect Control | 10.1186/s13756-020-00770-1 | 2020 | |
| Genetics | Detection and molecular characterization of VRE isolates in Slovakia from stool samples positive for Clostridioides difficile toxins. | Kuzma J, Palcova L, Timko J, Bastova V, Janoscova V, Chmelar D. | Folia Microbiol (Praha) | 10.1007/s12223-022-01002-2 | 2022 | |
| Protective Functions of Group 3 Late Embryogenesis Abundant (G3LEA) Proteins in Enterococcus faecium During Vancomycin Treatment. | Song A, Kim B, Kim E, Sung JH, Park Y, Park S, Park T, Kim JK, Jeong Y, Lee SG. | Indian J Microbiol | 10.1007/s12088-020-00899-y | 2020 | | |
| Clonal distribution of vancomycin-resistant Enterococcus faecium in Turkey and the new singleton ST733. | Erdem F, Kayacan C, Oncul O, Karagoz A, Aktas Z. | J Clin Lab Anal | 10.1002/jcla.23541 | 2020 | | |
| Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts. | Zalegh I, Bourhia M, Zerouali K, Katfy K, Nayme K, Khallouki F, Benzaarate I, Mohammad Salamatullah A, Alzahrani A, Nafidi HA, Akssira M, Ait Mhand R. | Evid Based Complement Alternat Med | 10.1155/2022/7467279 | 2022 | | |
| Hospital-acquired and zoonotic bacteria from a veterinary hospital and their associated antimicrobial-susceptibility profiles: A systematic review. | Sebola DC, Oguttu JW, Kock MM, Qekwana DN. | Front Vet Sci | 10.3389/fvets.2022.1087052 | 2022 | | |
| A Conjugative MDR pMG1-Like Plasmid Carrying the lsa(E) Gene of Enterococcus faecium With Potential Transmission to Staphylococcus aureus. | Yan XM, Wang J, Tao XX, Jia HB, Meng FL, Yang H, You YH, Zheng B, Hu Y, Bu XX, Zhang JZ. | Front Microbiol | 10.3389/fmicb.2021.667415 | 2021 | | |
| Overview of Antimicrobial Resistant ESKAPEE Pathogens in Food Sources and Their Implications from a One Health Perspective. | Oyenuga N, Cobo-Diaz JF, Alvarez-Ordonez A, Alexa EA. | Microorganisms | 10.3390/microorganisms12102084 | 2024 | | |
| Multi-drug-resistant Enterococcus faecium bacteraemia in a liver transplant recipient. | Summers NA, Gharbin J, Friedman-Moraco R, Lyon GM, Lutgring J. | JMM Case Rep | 10.1099/jmmcr.0.005172 | 2019 | | |
| Enterococcus spp.: Is It a Bad Choice for a Good Use-A Conundrum to Solve? | Ferchichi M, Sebei K, Boukerb AM, Karray-Bouraoui N, Chevalier S, Feuilloley MGJ, Connil N, Zommiti M. | Microorganisms | 10.3390/microorganisms9112222 | 2021 | | |
| Pathogenicity | Neonatal sepsis due to glycopeptide resistant Enterococcus faecium from colonized maternal gut- rare case evidence. | Subramanya SH, Amberpet R, Chaudhary D, Nayak N, Padukone S, Bairy I, Gokhale S. | Antimicrob Resist Infect Control | 10.1186/s13756-019-0490-x | 2019 | |
| Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis. | Borgmann S, Riess B, Siegmund R, Werner G, Klare I. | Ther Clin Risk Manag | 10.2147/tcrm.s179208 | 2019 | | |
| Development of a Multiplex Polymerase Chain Reaction-Based DNA Lateral Flow Assay as a Point-of-Care Diagnostic for Fast and Simultaneous Detection of MRSA and Vancomycin Resistance in Bacteremia. | Kashef MT, Helmy OM. | Diagnostics (Basel) | 10.3390/diagnostics12112691 | 2022 | | |
| Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia. | Ejaz M, Syed MA, Jackson CR, Sharif M, Faryal R. | Antibiotics (Basel) | 10.3390/antibiotics12060972 | 2023 | | |
| Genotypic characterization of vancomycin-resistant Enterococcus causing urinary tract infection in northern India. | Das AK, Dudeja M, Kohli S, Ray P. | Indian J Med Res | 10.4103/ijmr.ijmr_2554_19 | 2022 | | |
| A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in Enterococcus. | Wada Y, Harun A, Yean CY, Zaidah AR. | Diagnostics (Basel) | 10.3390/diagnostics13040722 | 2023 | | |
| Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis. | Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal JS. | Biomed Res Int | 10.1155/2022/5419874 | 2022 | | |
| Effect of biogenic bismuth nanoparticle on the expression of New Delhi metallo-beta-lactamase (NDM) gene in Multidrug-Resistant Klebsiella pneumoniae. | Sadeghi Dousari A, Shakibaie M, Hosseini-Nave H, Forootanfar H. | Heliyon | 10.1016/j.heliyon.2024.e32549 | 2024 | | |
| Sesquiterpenoids from Tussilago farfara Flower Bud Extract for the Eco-Friendly Synthesis of Silver and Gold Nanoparticles Possessing Antibacterial and Anticancer Activities. | Lee YJ, Song K, Cha SH, Cho S, Kim YS, Park Y. | Nanomaterials (Basel) | 10.3390/nano9060819 | 2019 | | |
| Microbiological Assessment of the FilmArray Blood Culture Identification 2 Panel: Potential Impact in Critically Ill Patients. | Mauri C, Consonni A, Briozzo E, Giubbi C, Meroni E, Tonolo S, Luzzaro F. | Antibiotics (Basel) | 10.3390/antibiotics12081247 | 2023 | | |
| Virulence and Antibiotic Resistance Genes in Enterococcus from Wastewater for Reuse and Their Health Impact. | Adegoke AA, Madu CE, Reddy P, Fatunla OK, Stenstrom TA, Okoh AI. | Microorganisms | 10.3390/microorganisms13051045 | 2025 | | |
| The Silent Threat: Antimicrobial-Resistant Pathogens in Food-Producing Animals and Their Impact on Public Health. | Almansour AM, Alhadlaq MA, Alzahrani KO, Mukhtar LE, Alharbi AL, Alajel SM. | Microorganisms | 10.3390/microorganisms11092127 | 2023 | | |
| Clinical Perspective of Antimicrobial Resistance in Bacteria. | Zhu Y, Huang WE, Yang Q. | Infect Drug Resist | 10.2147/idr.s345574 | 2022 | | |
| Pathogenicity | An Organogold Compound as Potential Antimicrobial Agent against Drug-Resistant Bacteria: Initial Mechanistic Insights. | Chakraborty P, Oosterhuis D, Bonsignore R, Casini A, Olinga P, Scheffers DJ. | ChemMedChem | 10.1002/cmdc.202100342 | 2021 | |
| Bacterial Antibiotic Resistance: The Most Critical Pathogens. | Mancuso G, Midiri A, Gerace E, Biondo C. | Pathogens | 10.3390/pathogens10101310 | 2021 | | |
| Exploring Beneficial Properties of the Bacteriocinogenic Enterococcus faecium ST10Bz Strain Isolated from Boza, a Bulgarian Cereal-Based Beverage. | Valledor SJD, Bucheli JEV, Holzapfel WH, Todorov SD. | Microorganisms | 10.3390/microorganisms8101474 | 2020 | | |
| Prevalence of vancomycin resistance among isolates of enterococci in Iran: a systematic review and meta-analysis. | Moghimbeigi A, Moghimbeygi M, Dousti M, Kiani F, Sayehmiri F, Sadeghifard N, Nazari A. | Adolesc Health Med Ther | 10.2147/ahmt.s180489 | 2018 | | |
| Isolation of New Strains of Lactic Acid Bacteria from the Vaginal Microbiome of Postmenopausal Women and their Probiotic Characteristics. | Barman I, Seo H, Kim S, Rahim MA, Yoon Y, Hossain MS, Shuvo MSH, Song HY. | Curr Microbiol | 10.1007/s00284-024-04034-8 | 2025 | | |
| In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype: Clinical Implications for Infective Endocarditis. | Garcia-Gonzalez J, Canas MA, Cuervo G, Hernandez-Meneses M, Verdejo MA, Bodro M, Diez de Los Rios J, Gasch O, Ribera A, Falces C, Perissinotti A, Vidal B, Quintana E, Moreno A, Piquet M, Roca I, Fernandez-Pittol M, San Jose-Villar SM, Garcia-de-la-Maria C, Miro JM, The Hospital Clinic Endocarditis Study Group. | Microorganisms | 10.3390/microorganisms12122511 | 2024 | | |
| Unexpected benefit of COVID-19 hospital restrictions: Reduction in patients isolating with multidrug resistant organisms after restrictions were lifted. | Elliott TM, Hurst C, Doidge M, Hurst T, Harris PN, Gordon LG. | Infect Dis Health | 10.1016/j.idh.2021.08.001 | 2022 | | |
| Antibiotic resistance gene pollution in poultry farming environments and approaches for mitigation: A system review. | Chen Y, Liu Y, Zhao C, Ma J, Guo J. | Poult Sci | 10.1016/j.psj.2025.104858 | 2025 | | |
| Antibiotic resistances from slaughterhouse effluents and enhanced antimicrobial blue light technology for wastewater decontamionation. | Cong X, Krolla P, Khan UZ, Savin M, Schwartz T. | Environ Sci Pollut Res Int | 10.1007/s11356-023-29972-x | 2023 | | |
| Antibiogram Pattern and Virulence Trait Characterization of Enterococcus Species Clinical Isolates in Eastern India: A Recent Analysis. | Mohanty S, Behera B. | J Lab Physicians | 10.1055/s-0042-1750085 | 2022 | | |
| Pathogenicity | Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant E. faecium, S. aureus, and Wild-Type E. coli. | Wu CL, Hsueh JY, Yip BS, Chih YH, Peng KL, Cheng JW. | Int J Mol Sci | 10.3390/ijms21134578 | 2020 | |
| Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium. | She P, Wang Y, Li Y, Zhou L, Li S, Zeng X, Liu Y, Xu L, Wu Y. | Front Microbiol | 10.3389/fmicb.2021.579806 | 2021 | | |
| Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections. | Shortridge D, Flamm RK. | Clin Infect Dis | 10.1093/cid/ciz003 | 2019 | | |
| Droplet digital PCR aids in the diagnosis of children with fever of unknown origin --A typical case report. | Yang Y, Hua C, Liu Y, Yang C, Mi Y, Qiu W. | Heliyon | 10.1016/j.heliyon.2024.e30961 | 2024 | | |
| Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study. | Zheng G, Zhang Y, Zhang L, Qian L, Cai Y, Lv H, Kang X, Guo D, Wang X, Huang J, Gao Z, Guan X, Zhang G. | Sci Rep | 10.1038/s41598-020-58670-8 | 2020 | | |
| An Evaluation of a Syndromic Molecular Panel in Optimising the Microbiological Diagnosis and Antimicrobial Therapy of Suspected Osteoarticular Infections in Paediatric Patients. | Agosta M, Cortazzo V, Onori M, Lucignano B, Vrenna G, Rossitto M, Pereyra Boza MDC, Fox V, Roversi M, Musolino A, Krzysztofiak A, Lancella L, Giordano M, Falciglia F, Porzio O, Villani A, Perno CF, Bernaschi P. | Diagnostics (Basel) | 10.3390/diagnostics15050566 | 2025 | | |
| Rapid Detection of vanA Resistance Gene from E. faecalis Clinical Isolates Using Duplex Loop-Mediated Isothermal Amplification and Triplex PCR Assay. | Azizi M, Motamedi H, Hossainpour H, Abiri R, Kashef M, Ahmadi K, Moradi J, Alvandi A. | Biomed Res Int | 10.1155/2022/4384196 | 2022 | | |
| High-Quality Draft Genome Sequence of the Multidrug-Resistant Clinical Isolate Enterococcus faecium VRE16. | de Mello SS, Van Tyne D, Dabul AN, Gilmore MS, Camargo IL. | Genome Announc | 10.1128/genomea.00992-16 | 2016 | | |
| Emergence of Vancomycin-resistant Enterococci at a Teaching Hospital, Saudi Arabia. | Alotaibi FE, Bukhari EE. | Chin Med J (Engl) | 10.4103/0366-6999.198923 | 2017 | | |
| Detecting antibiotic resistance: classical, molecular, advanced bioengineering, and AI-enhanced approaches. | Aldea AC, Diguta FC, Presacan O, Voaides C, Toma RC, Matei F. | Front Microbiol | 10.3389/fmicb.2025.1673343 | 2025 | | |
| Enzymology | Detection of vancomycin resistance in enterococcus species isolated from clinical samples and feces of colonized patients by phenotypic and genotypic methods. | Biswas PP, Dey S, Adhikari L, Sen A. | Indian J Pathol Microbiol | 10.4103/0377-4929.182015 | 2016 | |
| Synthesis and evaluation of antibacterial and antibiofilm agents based on phenylamino-substituted 1,4-benzoquinones. | Custodio Leite TO, Novais JS, C de Carvalho BL, F Dias FR, C Martins NR, da Silva AR, Geraldo RB, da Conceicao NC, Ratcliffe N, Ferreira VF, Castro HC, Cunha AC. | Future Med Chem | 10.1080/17568919.2024.2400954 | 2024 | | |
| The Prevalence of Virulent and Multidrug-Resistant Enterococci in River Water and in Treated and Untreated Municipal and Hospital Wastewater. | Gotkowska-Plachta A. | Int J Environ Res Public Health | 10.3390/ijerph18020563 | 2021 | | |
| Enzymology | New and promising anti-bacterials: Can this promise be sustained? | Saran S, Rao NS, Azim A. | J Anaesthesiol Clin Pharmacol | 10.4103/joacp.joacp_113_19 | 2020 | |
| Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus. | Koteva K, Xu M, Wang W, Fiebig-Comyn AA, Cook MA, Coombes BK, Wright GD. | J Med Chem | 10.1021/acs.jmedchem.3c00633 | 2023 | | |
| Liofilchem(®) Chromatic VRE and vancomycin MIC Test Strip detected glycopeptide resistance in a vanB neonatal Enterococcus faecium isolate showing alternate vancomycin susceptibility and resistance with bioMérieux Vitek2. | Savini V, Marrollo R, Coclite E, Fusilli P, D'Incecco C, Fazii P, Gherardi G. | Int J Clin Exp Pathol | 2014 | | ||
| Flower-Based Green Synthesis of Metallic Nanoparticles: Applications beyond Fragrance. | Kumar H, Bhardwaj K, Kuca K, Kalia A, Nepovimova E, Verma R, Kumar D. | Nanomaterials (Basel) | 10.3390/nano10040766 | 2020 | | |
| Do Your Kids Get What You Paid for? Evaluation of Commercially Available Probiotic Products Intended for Children in the Republic of the Philippines and the Republic of Korea. | Dioso CM, Vital P, Arellano K, Park H, Todorov SD, Ji Y, Holzapfel W. | Foods | 10.3390/foods9091229 | 2020 | | |
| Impact of Exogenous Lactiplantibacillus plantarum on the Gut Microbiome of Hematopoietic Stem Cell Transplantation Patients Colonized by Multidrug-Resistant Bacteria: An Observational Study. | Moraes BDGC, Martins RCR, Fonseca JVDS, Franco LAM, Pereira GCO, Bartelli TF, Cortes MF, Scaccia N, Santos CF, Musqueira PT, Otuyama LJ, Pylro VS, Mariano L, Rocha V, Witkin SS, Sabino E, Guimaraes T, Costa SF. | Antibiotics (Basel) | 10.3390/antibiotics13111010 | 2024 | | |
| Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in Enterococcus faecalis. | Conti P, Lazzaro LM, Longo F, Lenzo F, Giardina A, Fortuna SA, Stefani S, Campanile F. | Antibiotics (Basel) | 10.3390/antibiotics13010065 | 2024 | | |
| Pathogenicity | Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Bermuda. | Akpaka PE, Kissoon S, Wilson C, Jayaratne P, Smith A, Golding GR. | PLoS One | 10.1371/journal.pone.0171317 | 2017 | |
| Pathogenicity | Emergence of High-level Gentamicin Resistance among Enterococci Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working. | Labibzadeh M, Kaydani GA, Savari M, Ekrami A. | Pol J Microbiol | 10.21307/pjm-2018-043 | 2018 | |
| Pathogenicity | High Prevalence of vanM in Vancomycin-Resistant Enterococcus faecium Isolates from Shanghai, China. | Chen C, Sun J, Guo Y, Lin D, Guo Q, Hu F, Zhu D, Xu X, Wang M. | Antimicrob Agents Chemother | 10.1128/aac.01732-15 | 2015 | |
| Pathogenicity | Antibacterial Activity of Chalcone and Dihydrochalcone Compounds from Uvaria chamae Roots against Multidrug-Resistant Bacteria. | Koudokpon H, Armstrong N, Dougnon TV, Fah L, Hounsa E, Bankole HS, Loko F, Chabriere E, Rolain JM. | Biomed Res Int | 10.1155/2018/1453173 | 2018 | |
| Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections. | Jiang L, Lin J, Taggart CC, Bengoechea JA, Scott CJ. | J Interdiscip Nanomed | 10.1002/jin2.48 | 2018 | | |
| Pathogenicity | Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum beta-Lactamase/AmpC-producing (ESBL/AmpC) Enterobacteriaceae from Humans and Pets. | Iseppi R, Di Cerbo A, Messi P, Sabia C. | Antibiotics (Basel) | 10.3390/antibiotics9040152 | 2020 | |
| Antimicrobial resistance patterns and virulence factors of enterococci isolates in hospitalized burn patients. | Shokoohizadeh L, Ekrami A, Labibzadeh M, Ali L, Alavi SM. | BMC Res Notes | 10.1186/s13104-017-3088-5 | 2018 | | |
| Development and evaluation of a Quadruplex Taq Man real-time PCR assay for simultaneous detection of clinical isolates of Enterococcus faecalis, Enterococcus faecium and their vanA and vanB genotypes. | Naserpour Farivar T, Najafipour R, Johari P, Aslanimehr M, Peymani A, Jahani Hashemi H, Mirzaui B. | Iran J Microbiol | 2014 | | ||
| Metabolism | Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing. | Ozsoy S, Ilki A. | Braz J Microbiol | 10.1016/j.bjm.2016.12.012 | 2017 | |
| Genetics | Comparative genomics of multidrug-resistant Enterococcus spp. isolated from wastewater treatment plants. | Sanderson H, Ortega-Polo R, Zaheer R, Goji N, Amoako KK, Brown RS, Majury A, Liss SN, McAllister TA. | BMC Microbiol | 10.1186/s12866-019-1683-4 | 2020 | |
| Enzymology | Safety, beneficial and technological properties of Enterococcus faecium isolated from Brazilian cheeses. | Dos Santos KM, Vieira AD, Salles HO, Oliveira Jda S, Rocha CR, Borges Mde F, Bruno LM, Franco BD, Todorov SD. | Braz J Microbiol | 10.1590/s1517-838246120131245 | 2015 | |
| ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics. | Kurbatfinski N, Kramer CN, Goodman SD, Bakaletz LO. | Front Microbiol | 10.3389/fmicb.2023.1202215 | 2023 | | |
| Antimicrobial activity and the presence of virulence factors and bacteriocin structural genes in Enterococcus faecium CM33 isolated from ewe colostrum. | Nami Y, Haghshenas B, Haghshenas M, Yari Khosroushahi A. | Front Microbiol | 10.3389/fmicb.2015.00782 | 2015 | | |
| Molecular distribution of biocide resistance genes and susceptibility to biocides among vancomycin resistant Staphylococcus aureus (VRSA) isolates from intensive care unit (ICU) of cardiac hospital- A first report from Pakistan. | Asghar MU, Ain NU, Zaidi AH, Tariq M. | Heliyon | 10.1016/j.heliyon.2023.e22120 | 2023 | | |
| The Impact of Plant-Derived Polyphenols on Combating Efflux-Mediated Antibiotic Resistance. | Duda-Madej A, Viscardi S, Niezgodka P, Szewczyk W, Winska K. | Int J Mol Sci | 10.3390/ijms26094030 | 2025 | | |
| Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit. | Amberpet R, Sistla S, Parija SC, Rameshkumar R. | J Lab Physicians | 10.4103/jlp.jlp_32_17 | 2018 | | |
| Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections. | Gallerani A, Gatti M, Bedini A, Casolari S, Orlando G, Puzzolante C, Franceschini E, Menozzi M, Santoro A, Barp N, Volpi S, Soffritti A, Pea F, Mussini C, Meschiari M. | Antibiotics (Basel) | 10.3390/antibiotics12111639 | 2023 | | |
| Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future. | Galgano M, Pellegrini F, Catalano E, Capozzi L, Del Sambro L, Sposato A, Lucente MS, Vasinioti VI, Catella C, Odigie AE, Tempesta M, Pratelli A, Capozza P. | Antibiotics (Basel) | 10.3390/antibiotics14030222 | 2025 | | |
| A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections. | Agyeman WY, Bisht A, Gopinath A, Cheema AH, Chaludiya K, Khalid M, Nwosu M, Konka S, Khan S. | Cureus | 10.7759/cureus.29956 | 2022 | | |
| Community Acquired Enterococcal Urinary Tract Infections and Antibiotic Resistance Profile in North India. | Goel V, Kumar D, Kumar R, Mathur P, Singh S. | J Lab Physicians | 10.4103/0974-2727.176237 | 2016 | | |
| Beneficial and Safety Properties of a Bacteriocinogenic and Putative Probiotic Latilactobacillus sakei subsp. sakei 2a Strain. | Lipilkina TA, Xu C, Barbosa MS, Khramova VN, Shebeko SK, Ermakov AM, Ivanova IV, Todorov SD. | Foods | 10.3390/foods13233770 | 2024 | | |
| Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia. | Ngoi ST, Chong CW, Ponnampalavanar SSS, Tang SN, Idris N, Abdul Jabar K, Gregory MJ, Husain T, Teh CSJ. | Antimicrob Resist Infect Control | 10.1186/s13756-021-00936-5 | 2021 | | |
| A Modified Vancomycin Molecule Confers Potent Inhibitory Efficacy against Resistant Bacteria Mediated by Metallo-beta-Lactamases. | Zhai L, Liu Y, Jiang Y, Kong LY, Xiao J, Wang YX, Shi Y, Zhang YL, Yang KW. | Molecules | 10.3390/molecules27227685 | 2022 | | |
| Identification of a 2-Aminobenzimidazole Scaffold that Potentiates Gram-Positive Selective Antibiotics Against Gram-Negative Bacteria. | Nemeth AM, Young MM, Melander RJ, Smith RD, Ernst RK, Melander C. | Chembiochem | 10.1002/cbic.202400127 | 2024 | | |
| Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections. | Peri AM, Bauer MJ, Bergh H, Butkiewicz D, Paterson DL, Harris PN. | Heliyon | 10.1016/j.heliyon.2022.e09983 | 2022 | | |
| A Novel Biofilm Model System to Visualise Conjugal Transfer of Vancomycin Resistance by Environmental Enterococci. | Conwell M, Dooley JSG, Naughton PJ. | Microorganisms | 10.3390/microorganisms9040789 | 2021 | | |
| Antimicrobial Resistance of Enterococcus Species Isolated from Wild Mammals in Aragón, Spain. | Garcia LA, Torres C, Lopez AR, Rodriguez CO, Valencia CS. | J Vet Res | 10.2478/jvetres-2022-0020 | 2022 | | |
| Pathogenicity | Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches. | Karaman R, Jubeh B, Breijyeh Z. | Molecules | 10.3390/molecules25122888 | 2020 | |
| Non-thermal Plasma Treatment of ESKAPE Pathogens: A Review. | Scholtz V, Vankova E, Kasparova P, Premanath R, Karunasagar I, Julak J. | Front Microbiol | 10.3389/fmicb.2021.737635 | 2021 | | |
| Antimicrobial Resistance, Virulence Genes, and Biofilm Formation Capacity Among Enterococcus species From Yaks in Aba Tibetan Autonomous Prefecture, China. | Cui P, Feng L, Zhang L, He J, An T, Fu X, Li C, Zhao X, Zhai Y, Li H, Yan W, Li H, Luo X, Lei C, Wang H, Yang X. | Front Microbiol | 10.3389/fmicb.2020.01250 | 2020 | | |
| Vancomycin-resistant enteroccus faecium and enterococcus faecalis isolated from education hospital of iran. | Kafil HS, Asgharzadeh M. | Maedica (Bucur) | 2014 | | ||
| Pathogenicity | Pilot Screening to Determine Antimicrobial Synergies in a Multidrug-Resistant Bacterial Strain Library. | Kim SH, Park C, Chun HS, Lee DG, Choi JK, Lee HJ, Cho SY, Park SH, Choi SM, Choi JH, Yoo JH. | Microb Drug Resist | 10.1089/mdr.2015.0251 | 2016 | |
| Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study. | Adema JL, Lake LN, Stevens RW, Hogan BM, Schuetz AN, Tande AJ, Mara KC, Eberly AR, Rivera CG. | Open Forum Infect Dis | 10.1093/ofid/ofab611 | 2022 | | |
| Probiotics in Medicine: A Long Debate. | Stavropoulou E, Bezirtzoglou E. | Front Immunol | 10.3389/fimmu.2020.02192 | 2020 | | |
| A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis. | Lopez de Egea G, Gonzalez-Diaz A, Guedon G, Lao J, Berbel D, Casabella A, Marimon JM, Cercenado E, Fernandez-Delgado L, Chiapello H, Lacroix T, Dominguez MA, Leblond-Bourget N, Ardanuy C. | Antibiotics (Basel) | 10.3390/antibiotics12030579 | 2023 | | |
| Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review. | Matzaras R, Nikopoulou A, Protonotariou E, Christaki E. | Yale J Biol Med | 2022 | | ||
| Old and modern antibiotic structures with potential for today's infections. | Newman DJ. | ADMET DMPK | 10.5599/admet.1272 | 2022 | | |
| In Vitro Evaluation of Phytobiotic Mixture Antibacterial Potential against Enterococcus spp. Strains Isolated from Broiler Chicken. | Wodz K, Chodkowska KA, Iwinski H, Rozanski H, Wojciechowski J. | Int J Mol Sci | 10.3390/ijms25094797 | 2024 | | |
| Genetics | Transmission of Vancomycin-Resistant Enterococci in the Hospital Setting: Uncovering the Patient-Environment Interplay. | Correa-Martinez CL, Tonnies H, Frobose NJ, Mellmann A, Kampmeier S. | Microorganisms | 10.3390/microorganisms8020203 | 2020 | |
| Enterococcal biofilm-A nidus for antibiotic resistance transfer? | Conwell M, Dooley JSG, Naughton PJ. | J Appl Microbiol | 10.1111/jam.15441 | 2022 | | |
| Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. | Santajit S, Indrawattana N. | Biomed Res Int | 10.1155/2016/2475067 | 2016 | | |
| National surveillance on vancomycin-resistant Enterococcus faecium in Taiwan: emergence and widespread of ST414 and a Tn1546-like element with simultaneous insertion of IS1251-like and IS1678. | Kuo AJ, Su LH, Shu JC, Wang JT, Wang JH, Fung CP, Chia JH, Lu JJ, Wu TL. | PLoS One | 10.1371/journal.pone.0115555 | 2014 | | |
| Genetics | Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus. | Rengaraj R, Mariappan S, Sekar U, Kamalanadhan A. | J Clin Diagn Res | 10.7860/jcdr/2016/17552.7201 | 2016 | |
| Enzymology | High frequency distribution of heterogeneous vancomycin resistant Enterococcous faecium (VREfm) in Iranian hospitals. | Shokoohizadeh L, Mobarez AM, Zali MR, Ranjbar R, Alebouyeh M, Sakinc T, Ali L. | Diagn Pathol | 10.1186/1746-1596-8-163 | 2013 | |
| Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies. | Peri AM, Ling W, Furuya-Kanamori L, Harris PNA, Paterson DL. | BMC Infect Dis | 10.1186/s12879-022-07772-x | 2022 | | |
| Pathogenicity | A Japanese traditional medicine Hochuekkito promotes negative conversion of vancomycin-resistant Enterococci. | Kohno J, Kawamura T, Kikuchi A, Akaishi T, Takayama S, Ishii T. | Sci Rep | 10.1038/s41598-021-90890-4 | 2021 | |
| Rapid antibacterial activity of anodized aluminum-based materials impregnated with quaternary ammonium compounds for high-touch surfaces to limit transmission of pathogenic bacteria. | Jann J, Drevelle O, Chen XG, Auclair-Gilbert M, Soucy G, Faucheux N, Fortier LC. | RSC Adv | 10.1039/d1ra07159a | 2021 | | |
| Genetics | Genomic Landscape of Multidrug Resistance and Virulence in Enterococcus faecalis IRMC827A from a Long-Term Patient. | Borgio JF, AlJindan R, Alghourab LH, Alquwaie R, Aldahhan R, Alhur NF, AlEraky DM, Mahmoud N, Almandil NB, AbdulAzeez S. | Biology (Basel) | 10.3390/biology12101296 | 2023 | |
| Introducing new laboratory-developed molecular methods in the clinical microbiology laboratories. | Pouladfar G. | Iran J Med Sci | 2012 | | ||
| Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem. | Yadav G, Thakuria B, Madan M, Agwan V, Pandey A. | J Clin Diagn Res | 10.7860/jcdr/2017/27260.10474 | 2017 | | |
| New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care. | Peri AM, Stewart A, Hume A, Irwin A, Harris PNA. | Curr Infect Dis Rep | 10.1007/s11908-021-00755-0 | 2021 | | |
| Pharmacokinetic Interpretation of Applying Local Drug Delivery System for the Treatment of Deep Surgical Site Infection in the Spine. | Madadi AK, Sohn MJ. | Pharmaceutics | 10.3390/pharmaceutics16010094 | 2024 | | |
| Molecular Analysis of Vancomycin-Resistant Enterococci Isolated from Regional Hospitals in Trinidad and Tobago. | Akpaka PE, Kissoon S, Jayaratne P. | Adv Med | 10.1155/2016/8762691 | 2016 | | |
| Calves as Main Reservoir of Antibiotic Resistance Genes in Dairy Farms. | Salerno B, Cornaggia M, Sabatino R, Di Cesare A, Furlan M, Barco L, Orsini M, Cordioli B, Mantovani C, Bano L, Losasso C. | Front Public Health | 10.3389/fpubh.2022.918658 | 2022 | | |
| Detection of glycopeptide resistance genes in enterococci by multiplex PCR. | Bhatt P, Sahni AK, Praharaj AK, Grover N, Kumar M, Chaudhari CN, Khajuria A. | Med J Armed Forces India | 10.1016/j.mjafi.2014.03.005 | 2015 | | |
| Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2. | Rajan BM, Kannabiran K. | Int J Mol Cell Med | 2014 | | ||
| Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections. | Ton TP, Bright R, Truong VK, Vasilev K. | Small Sci | 10.1002/smsc.202500138 | 2025 | | |
| Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching Hospital. | Amberpet R, Sistla S, Parija SC, Thabah MM. | J Clin Diagn Res | 10.7860/jcdr/2016/20562.8418 | 2016 | | |
| Clinico-Microbiological Investigation of Catheter Associated Urinary Tract Infection by Enterococcus faecalis: vanA Genotype. | Padmavathy K, Praveen S, Madhavan R, Krithika N, Kiruthiga A. | J Clin Diagn Res | 10.7860/jcdr/2015/13856.6378 | 2015 | | |
| Molecular Characterization of Virulence Genes in Vancomycin-Resistant and Vancomycin-Sensitive Enterococci. | Biswas PP, Dey S, Sen A, Adhikari L. | J Glob Infect Dis | 10.4103/0974-777x.176141 | 2016 | | |
| The importance of "one health approach" to the AMR study and surveillance in Angola and other African countries. | da Costa RC, Serrano I, Chambel L, Oliveira M. | One Health | 10.1016/j.onehlt.2024.100691 | 2024 | | |
| Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds. | Schmidt S, Heimesaat MM, Fischer A, Bereswill S, Melzig MF. | Eur J Microbiol Immunol (Bp) | 10.1556/eujmi-d-14-00029 | 2014 | | |
| New type F lineage-related Tn1546 and a vanA/vanB type vancomycin-resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006-2007. | Khan MA, Shorman M, Al-Tawfiq JA, Hays JP. | Epidemiol Infect | 10.1017/s0950268812001574 | 2013 | | |
| Mechanism of Honey Bacteriostatic Action Against MRSA and VRE Involves Hydroxyl Radicals Generated from Honey's Hydrogen Peroxide. | Brudzynski K, Lannigan R. | Front Microbiol | 10.3389/fmicb.2012.00036 | 2012 | | |
| Phylogeny | Prevalence, antibiotic susceptibility and virulence factors of Enterococcus species in racing pigeons (Columba livia f. domestica). | Dolka B, Czopowicz M, Chrobak-Chmiel D, Ledwon A, Szeleszczuk P. | BMC Vet Res | 10.1186/s12917-019-2200-6 | 2020 | |
| Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance. | Carasi P, Racedo SM, Jacquot C, Elie AM, Serradell ML, Urdaci MC. | Front Immunol | 10.3389/fimmu.2017.00088 | 2017 | | |
| Characterization of Enterococcus Isolates Colonizing the Intestinal Tract of Intensive Care Unit Patients Receiving Selective Digestive Decontamination. | Bello Gonzalez TDJ, Pham P, Top J, Willems RJL, van Schaik W, van Passel MWJ, Smidt H. | Front Microbiol | 10.3389/fmicb.2017.01596 | 2017 | | |
| Antibiotic resistance and virulence genes in Enterococcus species isolated from raw and processed seafood. | Cardak M, Ozmen Togay S, Ay M, Karaalioglu O, Erol O, Bagci U. | J Food Sci Technol | 10.1007/s13197-021-05313-z | 2022 | | |
| Identification and Characterization of a High Vancomycin-Resistant Staphylococcus aureus Harboring VanA Gene Cluster Isolated from Diabetic Foot Ulcer. | Dezfulian A, Aslani MM, Oskoui M, Farrokh P, Azimirad M, Dabiri H, Salehian MT, Zali MR. | Iran J Basic Med Sci | 2012 | | ||
| Investigating antibiotic resistance in enterococci in Gabonese livestock. | Desire OE, Larson B, Richard O, Rolande MM, Serge KB. | Vet World | 10.14202/vetworld.2022.714-721 | 2022 | | |
| Ultraviolet disinfection of antibiotic resistant bacteria and their antibiotic resistance genes in water and wastewater. | McKinney CW, Pruden A. | Environ Sci Technol | 10.1021/es303652q | 2012 | | |
| Pathogenicity | Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far. | Walia K, Madhumathi J, Veeraraghavan B, Chakrabarti A, Kapil A, Ray P, Singh H, Sistla S, Ohri VC. | Indian J Med Res | 10.4103/ijmr.ijmr_226_18 | 2019 | |
| Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. | Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC. | Antimicrob Resist Infect Control | 10.1186/2047-2994-2-30 | 2013 | | |
| Pathogenicity | A New Kind of Quinonic-Antibiotic Useful Against Multidrug-Resistant S. aureus and E. faecium Infections. | Campanini-Salinas J, Andrades-Lagos J, Gonzalez Rocha G, Choquesillo-Lazarte D, Bollo Dragnic S, Faundez M, Alarcon P, Silva F, Vidal R, Salas-Huenuleo E, Kogan M, Mella J, Recabarren Gajardo G, Vasquez-Velasquez D. | Molecules | 10.3390/molecules23071776 | 2018 | |
| A locked nucleic acid (LNA)-based real-time PCR assay for the rapid detection of multiple bacterial antibiotic resistance genes directly from positive blood culture. | Zhu L, Shen D, Zhou Q, Li Z, Fang X, Li QZ. | PLoS One | 10.1371/journal.pone.0120464 | 2015 | | |
| Enzymology | Non-culture based assays for the detection of fungal pathogens. | Otasevic S, Momcilovic S, Stojanovic NM, Skvarc M, Rajkovic K, Arsic-Arsenijevic V. | J Mycol Med | 10.1016/j.mycmed.2018.03.001 | 2018 | |
| Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge. | Herrera-Hidalgo L, Fernandez-Rubio B, Luque-Marquez R, Lopez-Cortes LE, Gil-Navarro MV, de Alarcon A. | Antibiotics (Basel) | 10.3390/antibiotics12040704 | 2023 | | |
| Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. | Cheng VC, Chan JF, Tai JW, Ho YY, Li I, To KK, Ho PL, Yuen KY. | Emerg Health Threats J | 10.3134/ehtj.09.009 | 2009 | | |
| The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis. | Dekmezian M, Beal SG, Damashek MJ, Benavides R, Dhiman N. | Proc (Bayl Univ Med Cent) | 10.1080/08998280.2015.11929215 | 2015 | | |
| Pathogenicity | An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants. | Phetsang W, Blaskovich MA, Butler MS, Huang JX, Zuegg J, Mamidyala SK, Ramu S, Kavanagh AM, Cooper MA. | Bioorg Med Chem | 10.1016/j.bmc.2014.05.054 | 2014 | |
| Action and resistance mechanisms of antibiotics: A guide for clinicians. | Kapoor G, Saigal S, Elongavan A. | J Anaesthesiol Clin Pharmacol | 10.4103/joacp.joacp_349_15 | 2017 | | |
| Rapid Detection of VanA/B-Producing Vancomycin-Resistant Enterococci Using Lateral Flow Immunoassay. | Oueslati S, Gonzalez C, Volland H, Cattoir V, Bernabeu S, Girlich D, Dulac D, Plaisance M, Boutigny L, Dortet L, Simon S, Naas T. | Diagnostics (Basel) | 10.3390/diagnostics11101805 | 2021 | | |
| Pathogenicity | Genetic characterization of vancomycin-resistant enterococci isolates from wild rabbits. | Figueiredo N, Radhouani H, Goncalves A, Rodrigues J, Carvalho C, Igrejas G, Poeta P. | J Basic Microbiol | 10.1002/jobm.200800387 | 2009 | |
| Biocidal activity of metalloacid-coated surfaces against multidrug-resistant microorganisms. | Tetault N, Gbaguidi-Haore H, Bertrand X, Quentin R, van der Mee-Marquet N. | Antimicrob Resist Infect Control | 10.1186/2047-2994-1-35 | 2012 | | |
| Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels. | Sze DTT, Lau CCY, Chan TM, Ma ESK, Tang BSF. | BMC Microbiol | 10.1186/s12866-021-02403-y | 2021 | | |
| Genotyping of vancomycin resistant enterococci in arak hospitals. | Hoseini Zadeh A, Shojapour M, Nazari R, Akbari M, Sofian M, Abtahi H. | Jundishapur J Microbiol | 10.5812/jjm.8(4)2015.16287 | 2015 | | |
| Pathogenicity | Vancomycin-resistant enterococci from Portuguese wastewater treatment plants. | Araujo C, Torres C, Silva N, Carneiro C, Goncalves A, Radhouani H, Correia S, da Costa PM, Paccheco R, Zarazaga M, Ruiz-Larrea F, Poeta P, Igrejas G. | J Basic Microbiol | 10.1002/jobm.201000102 | 2010 | |
| Genetics | Evolution and Emergence of Antibiotic Resistance in Given Ecosystems: Possible Strategies for Addressing the Challenge of Antibiotic Resistance. | Selvarajan R, Obize C, Sibanda T, Abia ALK, Long H. | Antibiotics (Basel) | 10.3390/antibiotics12010028 | 2022 | |
| Molecular characterization of vanA-containing Enterococcus from migratory birds: song thrush (Turdus philomelos). | Silva N, Igrejas G, Felgar A, Goncalves A, Pacheco R, Poeta P. | Braz J Microbiol | 10.1590/s1517-838220120003000026 | 2012 | | |
| Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. | Thati V, Shivannavar CT, Gaddad SM. | Indian J Med Res | 10.4103/0971-5916.91001 | 2011 | | |
| Targeting the G-quadruplex as a novel strategy for developing antibiotics against hypervirulent drug-resistant Staphylococcus aureus. | Sultan M, Razzaq M, Lee J, Das S, Kannappan S, Subramani VK, Yoo W, Kim T, Lee HR, Chaurasia AK, Kim KK. | J Biomed Sci | 10.1186/s12929-024-01109-3 | 2025 | | |
| Phylogeny | Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children. | Aamodt H, Mohn SC, Maselle S, Manji KP, Willems R, Jureen R, Langeland N, Blomberg B. | BMC Infect Dis | 10.1186/s12879-015-0845-8 | 2015 | |
| Pathogenicity | Vancomycin-resistant gram-positive cocci isolated from the saliva of wild songbirds. | Ishihara S, Bitner JJ, Farley GH, Gillock ET. | Curr Microbiol | 10.1007/s00284-012-0278-1 | 2013 | |
| Pathogenicity | Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. | Yoon YK, Sim HS, Kim JY, Park DW, Sohn JW, Roh KH, Lee SE, Kim MJ. | Yonsei Med J | 10.3349/ymj.2009.50.5.637 | 2009 | |
| Antibiotic Resistance Profiles and ARG Detection from Isolated Bacteria in a Culture-Dependent Study at the Codfish Industry Level. | Ferri G, Lauteri C, Scattolini M, Vergara A. | Foods | 10.3390/foods12081699 | 2023 | | |
| Methicillin- and Vancomycin-Resistant Staphylococcus aureus From Humans and Ready-To-Eat Meat: Characterization of Antimicrobial Resistance and Biofilm Formation Ability. | Saber T, Samir M, El-Mekkawy RM, Ariny E, El-Sayed SR, Enan G, Abdelatif SH, Askora A, Merwad AMA, Tartor YH. | Front Microbiol | 10.3389/fmicb.2021.735494 | 2021 | | |
| Update on the emerging role of telavancin in hospital-acquired infections. | Nnedu ON, Pankey GA. | Ther Clin Risk Manag | 10.2147/tcrm.s57376 | 2015 | | |
| Pathogenicity | Genotypic diversity, antibiotic resistance and bacteriocin production of enterococci isolated from rhizospheres. | Klibi N, Ben Slimen N, Fhoula I, Lopez M, Ben Slama K, Daffonchio D, Boudabous A, Torres C, Ouzari H. | Microbes Environ | 10.1264/jsme2.me12041 | 2012 | |
| Molecular characterization of glycopeptide-resistant enterococci from hospitals of the picardy region (france). | Biendo M, Adjide C, Castelain S, Belmekki M, Rousseau F, Slama M, Ganry O, Schmit JL, Eb F. | Int J Microbiol | 10.1155/2010/150464 | 2010 | | |
| Flourishing Antibacterial Strategies for Osteomyelitis Therapy. | Wang X, Zhang M, Zhang M, Zhu T, Wei Q, Liu G, Ding J. | Adv Sci (Weinh) | 10.1002/advs.202206154 | 2023 | | |
| Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. | Perreten V, Vorlet-Fawer L, Slickers P, Ehricht R, Kuhnert P, Frey J. | J Clin Microbiol | 10.1128/jcm.43.5.2291-2302.2005 | 2005 | | |
| Multiresistant Bacteria Isolated from Activated Sludge in Austria. | Galler H, Feierl G, Petternel C, Reinthaler FF, Haas D, Habib J, Kittinger C, Luxner J, Zarfel G. | Int J Environ Res Public Health | 10.3390/ijerph15030479 | 2018 | | |
| Evaluation of antibiotic resistance dissemination by wastewater treatment plant effluents with different catchment areas in Germany. | Alexander J, Hembach N, Schwartz T. | Sci Rep | 10.1038/s41598-020-65635-4 | 2020 | | |
| Pathogenicity | Persistent, toxin-antitoxin system-independent, tetracycline resistance-encoding plasmid from a dairy Enterococcus faecium isolate. | Li X, Alvarez V, Harper WJ, Wang HH. | Appl Environ Microbiol | 10.1128/aem.05168-11 | 2011 | |
| Multi-Host Pathogen Staphylococcus aureus-Epidemiology, Drug Resistance and Occurrence in Humans and Animals in Poland. | Troscianczyk A, Nowakiewicz A, Kasela M, Malm A, Tracz AM, Hahaj-Siembida A, Osinska M, Gula S, Jankowiak I. | Antibiotics (Basel) | 10.3390/antibiotics12071137 | 2023 | | |
| Phylogeny | IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. | Werner G, Fleige C, Geringer U, van Schaik W, Klare I, Witte W. | BMC Infect Dis | 10.1186/1471-2334-11-80 | 2011 | |
| Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and Meta-analysis. | Dharmaratne P, Rahman N, Leung A, Ip M. | Ann Med | 10.1080/07853890.2021.1927170 | 2021 | | |
| Antimicrobial resistance profile of Enterococcus spp isolated from food in Southern Brazil. | Riboldi GP, Frazzon J, d'Azevedo PA, Frazzon AP. | Braz J Microbiol | 10.1590/s1517-838220090001000021 | 2009 | | |
| Enzymology | Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters. | Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Sutherland C, Kau AY, Goldner N, Bulow C, Nicolau DP, Walsh TJ. | Antimicrob Agents Chemother | 10.1128/aac.01168-21 | 2021 | |
| Phylogeny | Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. | Vankerckhoven V, Huys G, Huys G, Vancanneyt M, Snauwaert C, Swings J, Klare I, Witte W, Van Autgaerden T, Chapelle S, Lammens C, Goossens H. | Appl Environ Microbiol | 10.1128/aem.02474-07 | 2008 | |
| Enzymology | Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital. | Zubaidah AW, Ariza A, Azmi S. | Med J Malaysia | 2006 | | |
| The Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular Basis. | Hao H, Sander P, Iqbal Z, Wang Y, Cheng G, Yuan Z. | Front Microbiol | 10.3389/fmicb.2016.01626 | 2016 | | |
| Evaluation of the Broad-Range PCR/ESI-MS Technology in Blood Specimens for the Molecular Diagnosis of Bloodstream Infections. | Jordana-Lluch E, Gimenez M, Quesada MD, Rivaya B, Marco C, Dominguez MJ, Armestar F, Martro E, Ausina V. | PLoS One | 10.1371/journal.pone.0140865 | 2015 | | |
| Synthesis and evaluation of an amphiphilic deferoxamine:gallium-conjugated cationic random copolymer against a murine wound healing infection model of Pseudomonas aeruginosa. | Qiao J, Liu Z, Cui S, Nagy T, Xiong MP. | Acta Biomater | 10.1016/j.actbio.2021.03.005 | 2021 | | |
| Enzymology | Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. | Lee SC, Wu MS, Shih HJ, Huang SH, Chiou MJ, See LC, Siu LK. | BMC Infect Dis | 10.1186/1471-2334-13-163 | 2013 | |
| Pathogenicity | The vanB2 gene cluster of the majority of vancomycin-resistant Enterococcus faecium isolates from Taiwan is associated with the pbp5 gene and is carried by Tn5382 containing a novel insertion sequence. | Lu JJ, Chang TY, Perng CL, Lee SY. | Antimicrob Agents Chemother | 10.1128/aac.49.9.3937-3939.2005 | 2005 | |
| Frequency and co-colonization of vancomycin-resistant Enterococci and Candida in ICU-hospitalized children. | Shirvani F, Behzad A, Abdollahi N, Mohkam M, Sharifian M, Esfandiar N, Fallah F. | New Microbes New Infect | 10.1016/j.nmni.2021.100881 | 2021 | | |
| Metabolism | Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance. | Zeng D, Debabov D, Hartsell TL, Cano RJ, Adams S, Schuyler JA, McMillan R, Pace JL. | Cold Spring Harb Perspect Med | 10.1101/cshperspect.a026989 | 2016 | |
| Antimicrobial resistance in the environment: The Indian scenario. | Taneja N, Sharma M. | Indian J Med Res | 10.4103/ijmr.ijmr_331_18 | 2019 | | |
| Pathogenicity | Emerging vancomycin resistance in enterococci in India. | Ghoshal U, Garg A, Tiwari DP, Ayyagari A. | Indian J Pathol Microbiol | 2006 | | |
| Pathogenicity | Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant Staphylococcus aureus. | Joshi S, Joshi S, Mumtaz S, Singh J, Pasha S, Mukhopadhyay K. | Sci Rep | 10.1038/s41598-017-17234-z | 2018 | |
| A Decade-Long Commitment to Antimicrobial Resistance Surveillance in Portugal. | Marinho CM, Santos T, Goncalves A, Poeta P, Igrejas G. | Front Microbiol | 10.3389/fmicb.2016.01650 | 2016 | | |
| Pathogenicity | Antibiotic resistance profiles in cultivable microbiota isolated from some romanian natural fishery lakes included in Natura 2000 network. | Lazar V, Gheorghe I, Curutiu C, Savin I, Marinescu F, Cristea VC, Dobre D, Popa GL, Chifiriuc MC, Popa MI. | BMC Vet Res | 10.1186/s12917-021-02770-8 | 2021 | |
| Towards the standardization of Enterococcus culture methods for waterborne antibiotic resistance monitoring: A critical review of trends across studies. | Davis BC, Keenum I, Calarco J, Liguori K, Milligan E, Pruden A, Harwood VJ. | Water Res X | 10.1016/j.wroa.2022.100161 | 2022 | | |
| Cinacalcet exhibits rapid bactericidal and efficient anti-biofilm activities against multidrug-resistant Gram-positive pathogens. | Xiong Y, Liu S, Zheng J, Chen J, Wen Z, Deng X, Bai B, Li D, Yu Z, Han S, Liu X, Li P. | iScience | 10.1016/j.isci.2023.106378 | 2023 | | |
| SNP diversity of Enterococcus faecalis and Enterococcus faecium in a South East Queensland waterway, Australia, and associated antibiotic resistance gene profiles. | Rathnayake I, Hargreaves M, Huygens F. | BMC Microbiol | 10.1186/1471-2180-11-201 | 2011 | | |
| Mother-to-Neonate Transmission of Antibiotic-Resistant Bacteria: A Cross-Sectional Study. | Matok LA, Azrad M, Leshem T, Abuzahya A, Khamaisi T, Smolkin T, Peretz A. | Microorganisms | 10.3390/microorganisms9061245 | 2021 | | |
| Fluorescent antibiotics for real-time tracking of pathogenic bacteria. | Miao L, Liu W, Qiao Q, Li X, Xu Z. | J Pharm Anal | 10.1016/j.jpha.2020.09.003 | 2020 | | |
| Phylogeny | Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens. | Deplano A, Denis O, Rodriguez-Villalobos H, De Ryck R, Struelens MJ, Hallin M. | J Clin Microbiol | 10.1128/jcm.00528-11 | 2011 | |
| Pathogenicity | Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria. | Ceballos S, Kim C, Ding D, Mobashery S, Chang M, Torres C. | Antimicrob Agents Chemother | 10.1128/aac.00453-18 | 2018 | |
| Diagnosis of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry. | Greenwood-Quaintance KE, Uhl JR, Hanssen AD, Sampath R, Mandrekar JN, Patel R. | J Clin Microbiol | 10.1128/jcm.03217-13 | 2014 | | |
| Characterization of Staphylococci and Streptococci Isolated from Milk of Bovides with Mastitis in Egypt. | Ahmed W, Neubauer H, Tomaso H, El Hofy FI, Monecke S, Abdeltawab AA, Hotzel H. | Pathogens | 10.3390/pathogens9050381 | 2020 | | |
| Enzymology | From Conventional Disinfection to Antibiotic Resistance Control-Status of the Use of Chlorine and UV Irradiation during Wastewater Treatment. | Umar M. | Int J Environ Res Public Health | 10.3390/ijerph19031636 | 2022 | |
| Enzymology | Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin. | Ruczynski J, Rusiecka I, Turecka K, Kozlowska A, Alenowicz M, Gagalo I, Kawiak A, Rekowski P, Waleron K, Kocic I. | Sci Rep | 10.1038/s41598-019-40103-w | 2019 | |
| Antimicrobial Resistance, Virulence Determinants, and Biofilm Formation of Enterococcus Species From Ready-to-Eat Seafood. | Igbinosa EO, Beshiru A. | Front Microbiol | 10.3389/fmicb.2019.00728 | 2019 | | |
| Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain. | EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Arguello H, Berendonk T, Cavaco LM, Gaze W, Schmitt H, Topp E, Guerra B, Liebana E, Stella P, Peixe L. | EFSA J | 10.2903/j.efsa.2021.6651 | 2021 | | |
| Prevalence of Multidrug-Resistant Foodborne Pathogens and Indicator Bacteria from Edible Offal and Muscle Meats in Nashville, Tennessee. | Liu S, Kilonzo-Nthenge A, Nahashon SN, Pokharel B, Mafiz A, Nzomo M. | Foods | 10.3390/foods9091190 | 2020 | | |
| Different genetic supports for the tet(S) gene in Enterococci. | Novais C, Freitas AR, Silveira E, Baquero F, Peixe L, Roberts AP, Coque TM. | Antimicrob Agents Chemother | 10.1128/aac.00758-12 | 2012 | | |
| Enzymology | Outbreak of vancomycin resistant enterococcus in a hematology/oncology unit in a Korean University Hospital, and risk factors related to patients, staff, hospital care and facilities. | Oh HS, Kim EC, Oh MD, Choe KW. | Scand J Infect Dis | 10.1080/00365540410021117 | 2004 | |
| Enzymology | Detection of vanA-containing Enterococcus species in faecal microbiota of gilthead seabream (Sparus aurata). | Barros J, Andrade M, Radhouani H, Lopez M, Igrejas G, Poeta P, Torres C. | Microbes Environ | 10.1264/jsme2.me11346 | 2012 | |
| A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens. | Park S, Russo R, Westfall L, Shrestha R, Zimmerman M, Dartois V, Kurepina N, Kreiswirth B, Singleton E, Li SG, Mittal N, Ahn YM, Bilotta J, Connolly KL, Jerse AE, Freundlich JS, Perlin DS. | Antimicrob Agents Chemother | 10.1128/aac.00414-22 | 2022 | | |
| [Determination of the nosocomial origin of vancomycin-resistance strains of Enterococcus isolated from stool of patients in a hematology department]. | Trivier D, Savage C, Bauters F, Husson MO, Courcol RJ. | Pathol Biol (Paris) | 1999 | | ||
| Metabolism | The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. | Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, Marquette JP, Taburet Y, Prevost D, Dumas J, Leonard G, Stefanic P, Coyette J, Charlier P. | Cell Mol Life Sci | 10.1007/s00018-002-8500-0 | 2002 | |
| Metabolism | The Stringent Response Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection Through the Purine Biosynthetic Pathway. | Li L, Bayer AS, Cheung A, Lu L, Abdelhady W, Donegan NP, Hong JI, Yeaman MR, Xiong YQ. | J Infect Dis | 10.1093/infdis/jiaa202 | 2020 | |
| Pathogenicity | [Vancomycin resistant enterococcus in France. High prevalence in a young ambulatory care patient population]. | Guerin F, Perrier-Gros-Claude JD, Foissaud V, Masseron T, Thierry J. | Presse Med | 1998 | | |
| Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals. | Zhanel GG, Harding GK, Rosser S, Hoban DJ, Karlowsky JA, Alfa M, Kabani A, Embil J, Gin A, Williams T, Nicolle LE. | Can J Infect Dis | 10.1155/2000/356317 | 2000 | | |
| Pathogenicity | Multiresistant bacteria isolated from chicken meat in Austria. | Zarfel G, Galler H, Luxner J, Petternel C, Reinthaler FF, Haas D, Kittinger C, Grisold AJ, Pless P, Feierl G. | Int J Environ Res Public Health | 10.3390/ijerph111212582 | 2014 | |
| Phylogeny | Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry and real-time PCR in a combined protocol for diagnosis of bloodstream infections: a turnaround time approach. | Quiles MG, Boettger BC, Inoue FM, Monteiro J, Santos DW, Ponzio V, Carlesse F, Cappellano P, Carvalhaes CG, Pignatari ACC. | Braz J Infect Dis | 10.1016/j.bjid.2019.05.005 | 2019 | |
| Pathogenicity | In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods. | Jorgensen JH, Crawford SA, Kelly CC, Patterson JE. | Antimicrob Agents Chemother | 10.1128/aac.47.12.3760-3763.2003 | 2003 | |
| Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality? | Davido B, Moussiegt A, Dinh A, Bouchand F, Matt M, Senard O, Deconinck L, Espinasse F, Lawrence C, Fortineau N, Saleh-Mghir A, Caballero S, Escaut L, Salomon J. | Antimicrob Resist Infect Control | 10.1186/s13756-018-0390-5 | 2018 | | |
| Pathogenicity | In vitro antimicrobial susceptibility in clinical isolates of Enterococcus species. | Calderon-Jaimes E, Arredondo-Garcia JL, Aguilar-Ituarte F, Garcia-Roca P. | Salud Publica Mex | 10.1590/s0036-36342003000200005 | 2003 | |
| Enzymology | Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. | Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmund MB, Wenzel RP, Jones RN. | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(97)00059-x | 1997 | |
| Pathogenicity | [Epidemiological study on vancomycin-resistant enterococci from fecal samples in the east area of Japan]. | Oguri T, Misawa S, Nakamura A, Igari J, Ishii Y, Yamaguchi K. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.75.541 | 2001 | |
| Metabolism | Another Breaker of the Wall: the Biological Function of the Usp45 Protein of Lactococcus lactis. | Hernandez-Valdes JA, Huang C, Kok J, Kuipers OP. | Appl Environ Microbiol | 10.1128/aem.00903-20 | 2020 | |
| Metabolism | ICESluvan, a 94-kilobase mosaic integrative conjugative element conferring interspecies transfer of VanB-type glycopeptide resistance, a novel bacitracin resistance locus, and a toxin-antitoxin stabilization system. | Bjorkeng EK, Hjerde E, Pedersen T, Sundsfjord A, Hegstad K. | J Bacteriol | 10.1128/jb.02165-12 | 2013 | |
| Pathogenicity | Chlorhexidine bathing for the prevention of colonization and infection with multidrug-resistant microorganisms in a hematopoietic stem cell transplantation unit over a 9-year period: Impact on chlorhexidine susceptibility. | Mendes ET, Ranzani OT, Marchi AP, Silva MTD, Filho JUA, Alves T, Guimaraes T, Levin AS, Costa SF. | Medicine (Baltimore) | 10.1097/md.0000000000005271 | 2016 | |
| Genetics | Antibiotic Resistance-Susceptibility Profiles of Enterococcus faecalis and Streptococcus spp. From the Human Vagina, and Genome Analysis of the Genetic Basis of Intrinsic and Acquired Resistances. | Sirichoat A, Florez AB, Vazquez L, Buppasiri P, Panya M, Lulitanond V, Mayo B. | Front Microbiol | 10.3389/fmicb.2020.01438 | 2020 | |
| Pathogenicity | Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS). | Ballow CH, Biedenbach DJ, Rossi F, Jones RN, LA-ZAPS Study Group. | Braz J Infect Dis | 10.1590/s1413-86702002000300001 | 2002 | |
| Phylogeny | Evaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood cultures. | Eigner U, Weizenegger M, Fahr AM, Witte W. | J Clin Microbiol | 10.1128/jcm.43.10.5256-5262.2005 | 2005 | |
| Pathogenicity | Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolates. | Petersen PJ, Wang TZ, Dushin RG, Bradford PA. | Antimicrob Agents Chemother | 10.1128/aac.48.3.739-746.2004 | 2004 | |
| Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients. | Carlesse F, Cappellano P, Quiles MG, Menezes LC, Petrilli AS, Pignatari AC. | BMC Infect Dis | 10.1186/s12879-016-1792-8 | 2016 | | |
| Enzymology | Diagnosis by real-time polymerase chain reaction of pathogens and antimicrobial resistance genes in bone marrow transplant patients with bloodstream infections. | Menezes LC, Rocchetti TT, Bauab Kde C, Cappellano P, Quiles MG, Carlesse F, de Oliveira JS, Pignatari AC. | BMC Infect Dis | 10.1186/1471-2334-13-166 | 2013 | |
| Novel vancomycin-peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus. | Jelinkova P, Splichal Z, Jimenez AMJ, Haddad Y, Mazumdar A, Sur VP, Milosavljevic V, Kopel P, Buchtelova H, Guran R, Zitka O, Richtera L, Hegerova D, Heger Z, Moulick A, Adam V. | Infect Drug Resist | 10.2147/idr.s160975 | 2018 | | |
| A Culture-Independent Analysis of the Microbiota of Female Interstitial Cystitis/Bladder Pain Syndrome Participants in the MAPP Research Network. | Nickel JC, Stephens-Shields AJ, Landis JR, Mullins C, van Bokhoven A, Lucia MS, Henderson JP, Sen B, Krol JE, Ehrlich GD, MAPP Research Network. | J Clin Med | 10.3390/jcm8030415 | 2019 | | |
| Pathogenicity | Reverse transcription polymerase chain reaction method for the detection of glycopeptide resistance in enterococci. | Privitera O, Sisto F, Giuffrida V, Puntorieri M, Cascone C, Di Silvestro I, Rappazzo G, Stefani S. | J Microbiol Methods | 10.1016/s0167-7012(98)00096-7 | 1999 | |
| Pathogenicity | Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. | Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, Pamer EG. | J Clin Invest | 10.1172/jci43918 | 2010 | |
| Pathogenicity | Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum. | Speciale A, La Ferla K, Caccamo F, Nicoletti G. | Int J Antimicrob Agents | 10.1016/s0924-8579(99)00092-8 | 1999 | |
| Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria. | Russotto V, Cortegiani A, Graziano G, Saporito L, Raineri SM, Mammina C, Giarratano A. | Infect Drug Resist | 10.2147/idr.s48810 | 2015 | | |
| Pathogenicity | Reversing resistance: The next generation antibacterials. | Shah NJ. | Indian J Pharmacol | 10.4103/0253-7613.157109 | 2015 | |
| Pathogenicity | Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action. | Ndieyira JW, Bailey J, Patil SB, Vogtli M, Cooper MA, Abell C, McKendry RA, Aeppli G. | Sci Rep | 10.1038/srep41206 | 2017 | |
| A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species. | Yean CY, Yin LS, Lalitha P, Ravichandran M. | BMC Microbiol | 10.1186/1471-2180-7-112 | 2007 | | |
| Pathogenicity | Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. | Gutmann L, al-Obeid S, Billot-Klein D, Guerrier ML, Collatz E. | Antimicrob Agents Chemother | 10.1128/aac.38.4.824 | 1994 | |
| Enzymology | Environmental contamination with vancomycin-resistant enterococci from hospital sewage in Portugal. | Novais C, Coque TM, Ferreira H, Sousa JC, Peixe L. | Appl Environ Microbiol | 10.1128/aem.71.6.3364-3368.2005 | 2005 | |
| Pathogenicity | Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. | Dhawan VK, Nachum R, Bhat N, Tolbert L, Agrawal M. | West J Med | 1998 | | |
| Pathogenicity | Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. | Brunati C, Thomsen TT, Gaspari E, Maffioli S, Sosio M, Jabes D, Lobner-Olesen A, Donadio S. | J Antimicrob Chemother | 10.1093/jac/dkx395 | 2018 | |
| Molecular Mechanisms of Drug Resistance in Staphylococcus aureus. | Mlynarczyk-Bonikowska B, Kowalewski C, Krolak-Ulinska A, Marusza W. | Int J Mol Sci | 10.3390/ijms23158088 | 2022 | | |
| Comparison of PCR/electron spray ionization-time-of-flight-mass spectrometry versus traditional clinical microbiology for active surveillance of organisms contaminating high-use surfaces in a burn intensive care unit, an orthopedic ward and healthcare workers. | Yun HC, Kreft RE, Castillo MA, Ehrlich GD, Guymon CH, Crouch HK, Chung KK, Wenke JC, Hsu JR, Spirk TL, Costerton JW, Mende K, Murray CK. | BMC Infect Dis | 10.1186/1471-2334-12-252 | 2012 | | |
| How Streptococcus suis escapes antibiotic treatments. | Uruen C, Garcia C, Fraile L, Tommassen J, Arenas J. | Vet Res | 10.1186/s13567-022-01111-3 | 2022 | | |
| Pathogenicity | High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. | Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D, Dumas N, Limberger RJ, Patel JB. | Antimicrob Agents Chemother | 10.1128/aac.00576-06 | 2007 | |
| Role of telavancin in treatment of skin and skin structure infections. | Bonkowski J, Daniels AR, Peppard WJ. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s9027 | 2010 | | |
| Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance. | Peraman R, Sure SK, Dusthackeer VNA, Chilamakuru NB, Yiragamreddy PR, Pokuri C, Kutagulla VK, Chinni S. | Futur J Pharm Sci | 10.1186/s43094-021-00196-5 | 2021 | | |
| Pathogenicity | Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. | Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB. | Antimicrob Agents Chemother | 10.1128/aac.00908-07 | 2008 | |
| Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. | Koulenti D, Xu E, Mok IYS, Song A, Karageorgopoulos DE, Armaganidis A, Lipman J, Tsiodras S. | Microorganisms | 10.3390/microorganisms7080270 | 2019 | | |
| Enzymology | Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. | Gee T, Ellis R, Marshall G, Andrews J, Ashby J, Wise R. | Antimicrob Agents Chemother | 10.1128/aac.45.6.1843-1846.2001 | 2001 | |
| Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and evaluation for antibacterial/antifungal activity. | Ouahrouch A, Ighachane H, Taourirte M, Engels JW, Sedra MH, Lazrek HB. | Arch Pharm (Weinheim) | 10.1002/ardp.201400142 | 2014 | | |
| Pathogenicity | Antimicrobial Resistance in Enterococcus spp. of animal origin. | Torres C, Alonso CA, Ruiz-Ripa L, Leon-Sampedro R, Del Campo R, Coque TM. | Microbiol Spectr | 10.1128/microbiolspec.arba-0032-2018 | 2018 | |
| Pathogenicity | Predominance of vanA genotype among vancomycin-resistant Enterococcus isolates from poultry and swine in Costa Rica. | Bustamante W, Alpizar A, Hernandez S, Pacheco A, Vargas N, Herrera ML, Vargas A, Caballero M, Garcia F. | Appl Environ Microbiol | 10.1128/aem.69.12.7414-7419.2003 | 2003 | |
| Vancomycin-resistant enterococci in Canada revisited. | Johnston BL, Conly JM. | Can J Infect Dis | 10.1155/2000/626047 | 2000 | | |
| Reducing the Level of Undecaprenyl Pyrophosphate Synthase Has Complex Effects on Susceptibility to Cell Wall Antibiotics. | Lee YH, Helmann JD. | Antimicrob Agents Chemother | 10.1128/aac.00794-13 | 2013 | | |
| Stilbenoids: A Natural Arsenal against Bacterial Pathogens. | Mattio LM, Catinella G, Dallavalle S, Pinto A. | Antibiotics (Basel) | 10.3390/antibiotics9060336 | 2020 | | |
| Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). | Zhanel GG, Decorby M, Nichol KA, Baudry PJ, Karlowsky JA, Lagace-Wiens PR, McCracken M, Mulvey MR, Hoban DJ. | Can J Infect Dis Med Microbiol | 10.1155/2008/714846 | 2008 | | |
| Pathogenicity | Effects of amino acids on expression of enterococcal vancomycin resistance. | Zarlenga LJ, Gilmore MS, Sahm DF. | Antimicrob Agents Chemother | 10.1128/aac.36.4.902 | 1992 | |
| [Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant]. | Moreno Camacho A, Ruiz Camps I. | Enferm Infecc Microbiol Clin | 10.1016/j.eimc.2014.05.002 | 2014 | | |
| Phylogeny | Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. | Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. | J Clin Microbiol | 10.1128/jcm.31.3.653-658.1993 | 1993 | |
| Phylogeny | Species identification of enterococci via intergenic ribosomal PCR. | Tyrrell GJ, Bethune RN, Willey B, Low DE. | J Clin Microbiol | 10.1128/jcm.35.5.1054-1060.1997 | 1997 | |
| Pathogenicity | Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management. | Frickmann H, Masanta WO, Zautner AE. | Biomed Res Int | 10.1155/2014/375681 | 2014 | |
| Metabolism | Addiction toxin Fst has unique effects on chromosome segregation and cell division in Enterococcus faecalis and Bacillus subtilis. | Patel S, Weaver KE. | J Bacteriol | 10.1128/jb.00513-06 | 2006 | |
| Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies. | Lupo A, Coyne S, Berendonk TU. | Front Microbiol | 10.3389/fmicb.2012.00018 | 2012 | | |
| Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogs. | Rantala M, Lahti E, Kuhalampil J, Pesonen S, Jarvinen AK, Saijonmaa-Koulumies, Honkanen-Buzalski T. | Acta Vet Scand | 10.1186/1751-0147-45-37 | 2004 | | |
| Pathogenicity | Noncanonical vancomycin resistance cluster from Desulfitobacterium hafniense Y51. | Kalan L, Ebert S, Kelly T, Wright GD. | Antimicrob Agents Chemother | 10.1128/aac.01408-08 | 2009 | |
| Pathogenicity | [Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era]. | Rincon S, Panesso D, Diaz L, Carvajal LP, Reyes J, Munita JM, Arias CA. | Biomedica | 10.1590/s0120-41572014000500022 | 2014 | |
| Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. | Lauderdale TL, McDonald LC, Shiau YR, Chen PC, Wang HY, Lai JF, Ho M. | Antimicrob Agents Chemother | 10.1128/aac.46.2.525-527.2002 | 2002 | | |
| Pathogenicity | Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis. | Galm U, Heller S, Shapiro S, Page M, Li SM, Heide L. | Antimicrob Agents Chemother | 10.1128/aac.48.4.1307-1312.2004 | 2004 | |
| Current and novel antibiotics against resistant Gram-positive bacteria. | Perez F, Salata RA, Bonomo RA. | Infect Drug Resist | 10.2147/idr.s3545 | 2008 | | |
| Enzymology | Characteristics of doripenem: a new broad-spectrum antibiotic. | Alvarez-Lerma F, Grau S, Ferrandez O. | Drug Des Devel Ther | 10.2147/dddt.s3083 | 2009 | |
| Mechanisms of resistance to xenobiotics in human therapy. | Saves I, Masson JM. | Cell Mol Life Sci | 10.1007/s000180050170 | 1998 | | |
| Pathogenicity | Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s. | George RC, Uttley AH. | Epidemiol Infect | 10.1017/s0950268800030806 | 1989 | |
| Impact of antimicrobial agents and chemotherapy from 1972 to 1998. | Swartz MN. | Antimicrob Agents Chemother | 10.1128/aac.44.8.2009-2016.2000 | 2000 | | |
| Pathogenicity | Investigational antimicrobial agents of 2013. | Pucci MJ, Bush K. | Clin Microbiol Rev | 10.1128/cmr.00033-13 | 2013 | |
| Pathogenicity | Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. | Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. | Molecules | 10.3390/molecules23040795 | 2018 | |
| Presence of chromosomal elements resembling the composite structure Tn3701 in streptococci. | Le Bouguenec C, de Cespedes G, Horaud T. | J Bacteriol | 10.1128/jb.172.2.727-734.1990 | 1990 | | |
| Metabolism | Sugar metabolism, an additional virulence factor in enterobacteria. | Le Bouguenec C, Schouler C. | Int J Med Microbiol | 10.1016/j.ijmm.2010.04.021 | 2011 | |
| The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021. | European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC). | EFSA J | 10.2903/j.efsa.2023.7867 | 2023 | | |
| Nigella sativa oil extract: A natural novel specific conjugal transfer inhibitor of vancomycin resistance from vanA/B-resistant Enterococcus faecium to Staphylococcus aureus. | Ahmad AAM, Gharib AA, Elshorbgy I, Elewasy OA, Elmowalid GA | J Appl Microbiol | 10.1111/jam.15567 | 2022 | | |
| High-Resolution Genotyping Unveils Identical Ampicillin-Resistant Enterococcus faecium Strains in Different Sources and Countries: A One Health Approach. | Freitas AR, Tedim AP, Almeida-Santos AC, Duarte B, Elghaieb H, Abbassi MS, Hassen A, Novais C, Peixe L | Microorganisms | 10.3390/microorganisms10030632 | 2022 | | |
| Rapid and Reproducible MALDI-TOF-Based Method for the Detection of Vancomycin-Resistant Enterococcus faecium Using Classifying Algorithms. | Candela A, Arroyo MJ, Sanchez-Molleda A, Mendez G, Quiroga L, Ruiz A, Cercenado E, Marin M, Munoz P, Mancera L, Rodriguez-Temporal D, Rodriguez-Sanchez B | Diagnostics (Basel) | 10.3390/diagnostics12020328 | 2022 | | |
| Pathogenicity | Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility. | Kresken M, Klare I, Wichelhaus TA, Wohlfarth E, Layer-Nicolaou F, Neumann B, Werner G | J Glob Antimicrob Resist | 10.1016/j.jgar.2021.12.016 | 2021 | |
| Pathogenicity | Detection of Vancomycin-Resistant Enterococcus faecium Endocarditis After Clearance of Vancomycin-Sensitive Enterococcus faecium Bacteremia. | McEllistrem MC, Nordstrom HR, Lucas A, Decker BK, Van Tyne D | Microb Drug Resist | 10.1089/mdr.2021.0233 | 2021 | |
| Increasing Trend of Vancomycin-resistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-year Prospective Study. | Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS | Indian J Crit Care Med | 10.5005/jp-journals-10071-23916 | 2021 | | |
| Genetics | Genetic description of VanD phenotype vanA genotype in vancomycin-resistant Enterococcus faecium isolates from a Bone Marrow Transplantation Unit. | Marchi AP, Neto LVP, Cortes MF, de Castro Lima VAC, Martins RCR, Franco LAM, Rossi F, Rocha V, Levin AS, Costa SF | Braz J Microbiol | 10.1007/s42770-021-00634-9 | 2021 | |
| Pathogenicity | In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci. | Tong J, Jiang Y, Xu H, Jin X, Zhang L, Ying S, Yu W, Qiu Y | Drug Des Devel Ther | 10.2147/DDDT.S315061 | 2021 | |
| Phylogeny | Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan. | Fujiya Y, Harada T, Sugawara Y, Akeda Y, Yasuda M, Masumi A, Hayashi J, Tanimura N, Tsujimoto Y, Shibata W, Yamaguchi T, Kawahara R, Nishi I, Hamada S, Tomono K, Kakeya H | Sci Rep | 10.1038/s41598-021-94213-5 | 2021 | |
| Biotechnology | Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. | Pandey R, Mishra SK, Shrestha A | Infect Drug Resist | 10.2147/IDR.S306688 | 2021 | |
| Metabolism | Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium. | Gargvanshi S, Vemula H, Gutheil WG | J Bacteriol | 10.1128/JB.00230-21 | 2021 | |
| Metabolism | ddcP, pstB, and excess D-lactate impact synergism between vancomycin and chlorhexidine against Enterococcus faecium 1,231,410. | Bhardwaj P, Islam MZ, Kim C, Nguyen UT, Palmer KL | PLoS One | 10.1371/journal.pone.0249631 | 2021 | |
| Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients. | Hricova K, Stosova T, Kucova P, Fiserova K, Bardon J, Kolar M | Antibiotics (Basel) | 10.3390/antibiotics9110785 | 2020 | | |
| Pathogenicity | N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium. | Szucs Z, Bereczki I, Roth E, Milankovits M, Ostorhazi E, Batta G, Nagy L, Dombradi Z, Borbas A, Herczegh P | J Antibiot (Tokyo) | 10.1038/s41429-020-0313-6 | 2020 | |
| Phenotype | Impact of vanA-Positive Enterococcus faecium Exhibiting Diverse Susceptibility Phenotypes to Glycopeptides on 30-Day Mortality of Patients with a Bloodstream Infection. | Kim D, Yoon EJ, Hong JS, Lee H, Shin KS, Shin JH, Kim YR, Kim HS, Kim YA, Uh Y, Shin JH, Park YS, Jeong SH | Antimicrob Agents Chemother | 10.1128/AAC.02180-19 | 2020 | |
| VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells. | Vimberg V, Zieglerova L, Buriankova K, Branny P, Balikova Novotna G | Front Microbiol | 10.3389/fmicb.2020.00566 | 2020 | | |
| Pathogenicity | Quantifying Human Health Risks from Virginiamycin Use in Food Animals in China. | Cox LA Jr, Popken DA, Sun J, Liao XP, Fang LX | Risk Anal | 10.1111/risa.13466 | 2020 | |
| Genetics | First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a vanA Gene Cluster-Carrying Linear Plasmid. | Hashimoto Y, Kita I, Suzuki M, Hirakawa H, Ohtaki H, Tomita H | mSphere | 10.1128/mSphere.00102-20 | 2020 | |
| Pathogenicity | Antibiogram of Urinary Enterococcus Isolates from a Tertiary Care Hospital. | Bhat NR, Shivashankar SBK, Dhanashree B | Infect Disord Drug Targets | 10.2174/1871526520666200403140618 | 2021 | |
| Pathogenicity | Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey. | Asgin N, Otlu B | Infect Drug Resist | 10.2147/IDR.S191881 | 2020 | |
| Pathogenicity | Expression of VanA-type vancomycin resistance in a clinical isolate of Enterococcus faecium showing insertion of IS19 in the vanS gene. | Monteiro da Silva BN, Faria AR, Souza SDSR, Colodette SS, Morais JM, Teixeira LM, Merquior VLC | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2020.105897 | 2020 | |
| Pathogenicity | Novel Multidrug-Resistant Enterococcal Mobile Linear Plasmid pELF1 Encoding vanA and vanM Gene Clusters From a Japanese Vancomycin-Resistant Enterococci Isolate. | Hashimoto Y, Taniguchi M, Uesaka K, Nomura T, Hirakawa H, Tanimoto K, Tamai K, Ruan G, Zheng B, Tomita H | Front Microbiol | 10.3389/fmicb.2019.02568 | 2019 | |
| Genetics | Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary. | Franyo D, Kocsi B, Bukta EE, Szabo J, Dombradi Z | Folia Microbiol (Praha) | 10.1007/s12223-019-00751-x | 2019 | |
| Pathogenicity | TiCaPCON-Supported Pt- and Fe-Based Nanoparticles and Related Antibacterial Activity. | Ponomarev VA, Sheveyko AN, Permyakova ES, Lee J, Voevodin AA, Berman D, Manakhov AM, Michlicek M, Slukin PV, Firstova VV, Ignatov SG, Chepkasov IV, Popov ZI, Shtansky DV | ACS Appl Mater Interfaces | 10.1021/acsami.9b09649 | 2019 | |
| Pathogenicity | VanA-type vancomycin-resistant Enterococcus faecium ST1336 isolated from mussels in an anthropogenically impacted ecosystem. | Sacramento AG, Fernandes MR, Sellera FP, Dolabella SS, Zanella RC, Cerdeira L, Lincopan N | Mar Pollut Bull | 10.1016/j.marpolbul.2019.04.014 | 2019 | |
| Pathogenicity | Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda. | Kateete DP, Edolu M, Kigozi E, Kisukye J, Baluku H, Mwiine FN, Najjuka CF | BMC Infect Dis | 10.1186/s12879-019-4136-7 | 2019 | |
| Pathogenicity | In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci. | Wu T, Meyer K, Harrington AT, Danziger LH, Wenzler E | J Antimicrob Chemother | 10.1093/jac/dkz010 | 2019 | |
| Impact on Public Health of the Spread of High-Level Resistance to Gentamicin and Vancomycin in Enterococci. | Sparo M, Delpech G, Garcia Allende N | Front Microbiol | 10.3389/fmicb.2018.03073 | 2018 | | |
| Pathogenicity | Phenotypic and genetic characteristics of vancomycin-resistant Enterococcus faecium. | Yang J, Yuan Y, Tang M, Liu L, Yang K, Liu J | Microb Pathog | 10.1016/j.micpath.2018.12.046 | 2018 | |
| Genetics | Draft Genome Sequence of Enterococcus faecium CL-6729, a Clinical Isolate Showing Constitutive Vancomycin Resistance. | Monteiro da Silva BN, Faria AR, de Souza SDSR, Planet PJ, Merquior VLC, Teixeira LM | Microbiol Resour Announc | 10.1128/MRA.00888-18 | 2018 | |
| Genetics | Emergence of unusual vanA/vanB2 genotype in a highly mutated vanB2-vancomycin-resistant hospital-associated E. faecium background in Vietnam. | Santona A, Taviani E, Hoang HM, Fiamma M, Deligios M, Ngo TVQ, Van Le A, Cappuccinelli P, Rubino S, Paglietti B | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2018.07.006 | 2018 | |
| Phylogeny | Characterization of Clinical Vancomycin-Resistant Enterococcus faecium Isolated in Eastern Hungary. | Franyo D, Kocsi B, Lesinszki V, Paszti J, Kozak A, Bukta EE, Szabo J, Dombradi Z | Microb Drug Resist | 10.1089/mdr.2018.0074 | 2018 | |
| Pathogenicity | Vancomycin resistant Enterococci: A brief review. | Raza T, Ullah SR, Mehmood K, Andleeb S | J Pak Med Assoc | 8691 | 2018 | |
| Pathogenicity | Dissemination of VanA-Type Enterococcus faecium Isolates in Hungary. | Melegh S, Nyul A, Kovacs K, Kovacs T, Ghidan A, Dombradi Z, Szabo J, Berta B, Lesinszki V, Paszti J, Toth A, Mestyan G | Microb Drug Resist | 10.1089/mdr.2017.0296 | 2018 | |
| Pathogenicity | Analysis of the world epidemiological situation among vancomycin-resistant Enterococcus faecium infections and the current situation in Poland | Talaga-Cwiertnia K, Bulanda M | Przegl Epidemiol | 2018 | | |
| Pathogenicity | Presence of the esp gene in Enterococcus faecium derived from oropharyngeal microbiota of haematology patients. | Jovanovic M, Tosic T, Jovanovic S, Stosovic R, Stevanovic G, Velebit B, Zervos MJ | Arch Oral Biol | 10.1016/j.archoralbio.2018.01.008 | 2018 | |
| Genetic characteristics of VanA-type vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in Cuba. | Quinones D, Aung MS, Sousa Martins JP, Urushibara N, Kobayashi N | New Microbes New Infect | 10.1016/j.nmni.2017.12.001 | 2017 | | |
| Pathogenicity | Immunological responses against vancomycin-resistant Enterococcus faecium and Enterococcus faecalis by mice. | Cho YS, Lee MH, Kim JM, Lee HS, Yoo HS, Park YH, Ryu PD | J Immunoassay Immunochem | 10.1080/15321819.2017.1407943 | 2018 | |
| Genetics | Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan. | Chen CH, Lin LC, Chang YJ, Chang CY | Medicine (Baltimore) | 10.1097/MD.0000000000009000 | 2017 | |
| Enzymology | High rates of colonisation by ampicillin-resistant enterococci in residents of long-term care facilities in Porto, Portugal. | Freitas AR, Novais C, Duarte B, Pereira AP, Coque TM, Peixe L | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2017.11.007 | 2017 | |
| Enzymology | Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Infection. | Belley A, Lalonde-Seguin D, Arhin FF, Moeck G | Antimicrob Agents Chemother | 10.1128/AAC.01265-17 | 2017 | |
| Enzymology | First description in Europe of the emergence of Enterococcus faecium ST117 carrying both vanA and vanB genes, isolated in Greece. | Papagiannitsis CC, Malli E, Florou Z, Medvecky M, Sarrou S, Hrabak J, Petinaki E | J Glob Antimicrob Resist | 10.1016/j.jgar.2017.07.010 | 2017 | |
| Pathogenicity | Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014). | Duncan LR, Sader HS, Smart JI, Flamm RK, Mendes RE | J Glob Antimicrob Resist | 10.1016/j.jgar.2017.03.018 | 2017 | |
| Enzymology | First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit. | Inkster T, Coia J, Meunier D, Doumith M, Martin K, Pike R, Imrie L, Kane H, Hay M, Wiuff C, Wilson J, Deighan C, Hopkins KL, Woodford N, Hill R | J Hosp Infect | 10.1016/j.jhin.2017.07.003 | 2017 | |
| Phylogeny | Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran. | Shokouhi S, Darazam IA, Javadi A, Rouhani M, Ghasemnejad M | Infect Disord Drug Targets | 10.2174/1871526517666170210164649 | 2017 | |
| Enzymology | A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies. | Alatorre-Fernandez P, Mayoral-Teran C, Velazquez-Acosta C, Franco-Rodriguez C, Flores-Moreno K, Cevallos MA, Lopez-Vidal Y, Volkow-Fernandez P | Am J Infect Control | 10.1016/j.ajic.2016.10.002 | 2016 | |
| Metabolism | Incorporation of a Valine-Leucine-Lysine-Containing Substrate in the Bacterial Cell Wall. | Hansenova Manaskova S, Bikker FJ, Nazmi K, van Zuidam R, Slotman JA, van Cappellen WA, Houtsmuller AB, Veerman EC, Kaman WE | Bioconjug Chem | 10.1021/acs.bioconjchem.6b00381 | 2016 | |
| Phylogeny | Diversity of plasmids and Tn1546-type transposons among VanA Enterococcus faecium in Poland. | Wardal E, Kuch A, Gawryszewska I, Zabicka D, Hryniewicz W, Sadowy E | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-016-2804-8 | 2016 | |
| Pathogenicity | Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency. | Mendes RE, Castanheira M, Farrell DJ, Flamm RK, Sader HS, Jones RN | J Antimicrob Chemother | 10.1093/jac/dkw319 | 2016 | |
| Enzymology | Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012). | Freitas AR, Tedim AP, Francia MV, Jensen LB, Novais C, Peixe L, Sanchez-Valenzuela A, Sundsfjord A, Hegstad K, Werner G, Sadowy E, Hammerum AM, Garcia-Migura L, Willems RJ, Baquero F, Coque TM | J Antimicrob Chemother | 10.1093/jac/dkw312 | 2016 | |
| Pathogenicity | Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report. | Jakovac S, Bojic EF, Ibrisimovic MA, Tutis B, Ostojic M, Hukic M | Microb Drug Resist | 10.1089/mdr.2015.0355 | 2016 | |
| Metabolism | Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner. | van der Aart LT, Lemmens N, van Wamel WJ, van Wezel GP | Antimicrob Agents Chemother | 10.1128/AAC.00276-16 | 2016 | |
| Pathogenicity | Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. | Mendes RE, Flamm RK, Farrell DJ, Sader HS, Jones RN | J Chemother | 10.1179/1973947815Y.0000000050 | 2016 | |
| Pathogenicity | Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. | Yang JX, Li T, Ning YZ, Shao DH, Liu J, Wang SQ, Liang GW | Infect Genet Evol | 10.1016/j.meegid.2015.05.012 | 2015 | |
| Investigation of vancomycin resistant Enterococcus faecium outbreak in neonatal intensive care unit. | Cilo BD, Agca H, Efe K, Sinirtas M, Celebi S, Ozkan H, Koksal N, Hacimustafaoglu M, Ozakin C | Int J Clin Exp Med | 2014 | | ||
| Enzymology | Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method. | Mendes RE, Farrell DJ, Sader HS, Streit JM, Jones RN | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2014.12.011 | 2014 | |
| Phylogeny | Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital. | Merlo TP, Dabul AN, Camargo IL | Microb Drug Resist | 10.1089/mdr.2014.0077 | 2015 | |
| Neonatal septicaemia caused by vancomycin resistant enterococcus faecium-a case report. | Gb S, T N, Dr P, Tr H, R K | J Clin Diagn Res | 10.7860/JCDR/2014/10284.5220 | 2014 | | |
| Proteome | Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. | Ramos S, Chafsey I, Silva N, Hebraud M, Santos H, Capelo-Martinez JL, Poeta P, Igrejas G | J Proteomics | 10.1016/j.jprot.2014.10.012 | 2014 | |
| Pathogenicity | Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13). | Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN | J Antimicrob Chemother | 10.1093/jac/dku421 | 2014 | |
| Pathogenicity | [In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients]. | Medell M, Hart M, Batista ML | Biomedica | 10.1590/S0120-41572014000500007 | 2014 | |
| Pathogenicity | Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China. | Kang M, Xie Y, He C, Chen ZX, Guo L, Yang Q, Liu JY, Du Y, Ou QS, Wang LL | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-013-2029-z | 2014 | |
| Metabolism | Functional motions modulating VanA ligand binding unraveled by self-organizing maps. | Bouvier G, Duclert-Savatier N, Desdouits N, Meziane-Cherif D, Blondel A, Courvalin P, Nilges M, Malliavin TE | J Chem Inf Model | 10.1021/ci400354b | 2014 | |
| Phenotype | Diversity of Tn1546 in vanA-positive Enterococcus faecium clinical isolates with VanA, VanB, and VanD phenotypes and susceptibility to vancomycin. | Cha JO, Yoo JI, Kim HK, Kim HS, Yoo JS, Lee YS, Jung YH | J Appl Microbiol | 10.1111/jam.12300 | 2013 | |
| Genetics | Clinical and microbiological characteristics of vancomycin-resistant enterococci with the VanD phenotype and vanA genotype. | Song JY, Cheong HJ, Seo YB, Kim IS, Heo JY, Noh JY, Choi WS, Kim WJ | Jpn J Infect Dis | 10.7883/yoken.66.1 | 2013 | |
| High frequency of vancomycin-resistant enterococcus faecalis in an Iranian referral children medical hospital. | Pourakbari B, Aghdam MK, Mahmoudi S, Ashtiani MT, Sabouni F, Movahedi Z, Alyari AE, Sadeghi RH, Mamishi S | Maedica (Bucur) | 2012 | | ||
| Pathogenicity | In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci. | Hope R, Chaudhry A, Adkin R, Livermore DM | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2012.10.016 | 2013 | |
| Enzymology | Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina. | Delpech G, Pourcel G, Schell C, De Luca M, Basualdo J, Bernstein J, Grenovero S, Sparo M | Foodborne Pathog Dis | 10.1089/fpd.2012.1192 | 2012 | |
| Pathogenicity | Polyclonal outbreak of vancomycin-resistant Enterococcus faecium in a pediatric oncology department. | Iosifidis E, Karakoula K, Protonotariou E, Kaperoni M, Matapa E, Pournaras S, Koliouskas D, Sofianou D, Roilides E | J Pediatr Hematol Oncol | 10.1097/MPH.0b013e318257a5d3 | 2012 | |
| Pathogenicity | Vancomycin-resistant enterococci (VRE) isolates isolated in Rajavithi Hospital between 1999 and 2009. | Thongkoom P, Kanjanahareutai S, Chantrakooptungool S, Rahule S | J Med Assoc Thai | 2012 | | |
| Pathogenicity | Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. | Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE | Clin Infect Dis | 10.1093/cid/cir924 | 2012 | |
| Pathogenicity | Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak. | Zabicka D, Strzelecki J, Wozniak A, Strzelecki P, Sadowy E, Kuch A, Hryniewicz W | Antonie Van Leeuwenhoek | 10.1007/s10482-011-9681-z | 2011 | |
| Pathogenicity | [Frequency of vancomycin-resistant enterococci isolated from blood cultures from 2008 to 2010]. | Mihajlovic Ukropina M, Jelesic Z, Gusman V, Milosavljevic B | Med Pregl | 10.2298/mpns1110481m | 2011 | |
| Metabolism | Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland. | Kowalska-Krochmal B, Dworniczek E, Dolna I, Bania J, Walecka E, Seniuk A, Gosciniak G | Adv Med Sci | 10.2478/v10039-011-0022-2 | 2011 | |
| Enzymology | Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil. | Palazzo IC, Pitondo-Silva A, Levy CE, da Costa Darini AL | J Hosp Infect | 10.1016/j.jhin.2011.04.016 | 2011 | |
| Enzymology | Genetic organization and mode of action of a novel bacteriocin, bacteriocin 51: determinant of VanA-type vancomycin-resistant Enterococcus faecium. | Yamashita H, Tomita H, Inoue T, Ike Y | Antimicrob Agents Chemother | 10.1128/AAC.01274-10 | 2011 | |
| Pathogenicity | Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. | de Niederhausern S, Bondi M, Messi P, Iseppi R, Sabia C, Manicardi G, Anacarso I | Curr Microbiol | 10.1007/s00284-011-9868-6 | 2011 | |
| Proteomic characterization of vanA-containing Enterococcus recovered from Seagulls at the Berlengas Natural Reserve, W Portugal. | Radhouani H, Poeta P, Pinto L, Miranda J, Coelho C, Carvalho C, Rodrigues J, Lopez M, Torres C, Vitorino R, Domingues P, Igrejas G | Proteome Sci | 10.1186/1477-5956-8-48 | 2010 | | |
| Pathogenicity | Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia. | Pfaller MA, Mendes RE, Sader HS, Jones RN | J Antimicrob Chemother | 10.1093/jac/dkq335 | 2010 | |
| Pathogenicity | Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. | Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC | J Clin Microbiol | 10.1128/JCM.01522-10 | 2010 | |
| Enzymology | vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. | Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M | Antimicrob Agents Chemother | 10.1128/AAC.01710-09 | 2010 | |
| Pathogenicity | Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages. | Sletvold H, Johnsen PJ, Wikmark OG, Simonsen GS, Sundsfjord A, Nielsen KM | J Antimicrob Chemother | 10.1093/jac/dkq219 | 2010 | |
| Phylogeny | Characterization of vancomycin-resistant Enterococcus isolates from broilers in Selangor, Malaysia. | Getachew YM, Hassan L, Zakaria Z, Saleha AA, Kamaruddin MI, Che Zalina MZ | Trop Biomed | 2009 | | |
| Pathogenicity | Synthesis, crystal and antibacterial studies of diversely functionalized tetrahydropyridin-4-ol. | Aridoss G, Amirthaganesan S, Jeong YT | Bioorg Med Chem Lett | 10.1016/j.bmcl.2010.02.015 | 2010 | |
| Pathogenicity | Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates. | Raponi G, Ghezzi MC, Gherardi G, Lorino G, Dicuonzo G | J Med Microbiol | 10.1099/jmm.0.016444-0 | 2010 | |
| Enzymology | Characterisation of vancomycin-resistant enterococci from hospitalised patients at a tertiary centre over a seven-year period. | Chang CM, Wang LR, Lee HC, Lee NY, Wu CJ, Ko WC | J Hosp Infect | 10.1016/j.jhin.2009.10.025 | 2010 | |
| Phylogeny | [First isolation and detection of multiple clones of vancomycin-resistant enterococci in the pediatric unit of Van Yuzuncu Yil University Turkey]. | Guducuoglu H, Aktas E, Begendik Comert F, Aygul K, Ozlu N, Baykal S, Berktas M, Ceylan A | Mikrobiyol Bul | 2009 | | |
| Pathogenicity | Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates. | Arhin FF, Draghi DC, Pillar CM, Parr TR Jr, Moeck G, Sahm DF | Antimicrob Agents Chemother | 10.1128/AAC.00952-09 | 2009 | |
| Enzymology | vanA in Enterococcus faecium, Enterococcus faecalis, and Enterococcus casseliflavus detected in French cattle. | Haenni M, Saras E, Chatre P, Meunier D, Martin S, Lepage G, Menard MF, Lebreton P, Rambaud T, Madec JY | Foodborne Pathog Dis | 10.1089/fpd.2009.0303 | 2009 | |
| Pathogenicity | [Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Ninos de Cordoba]. | Reale AL, Depetri ML, Culasso C, Paviolo M, Cheguirian ML, Enrico MC, Ledesma EM, Vidal C, Glatstein E, Bertoni L | Rev Argent Microbiol | S0325-75412009000200006 | 2009 | |
| Enzymology | High prevalence of ST-78 infection-associated vancomycin-resistant Enterococcus faecium from hospitals in Asuncion, Paraguay. | Khan MA, Northwood JB, Loor RG, Tholen AT, Riera E, Falcon M, van Belkum A, van Westreenen M, Hays JP | Clin Microbiol Infect | 10.1111/j.1469-0691.2009.02898.x | 2009 | |
| Phylogeny | [Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]. | Surcouf C, Fabre M, Enouf V, Cade S, Soler C, Mac Nab C, Samson T, Foissaud V | Pathol Biol (Paris) | 10.1016/j.patbio.2009.04.004 | 2009 | |
| Pathogenicity | Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. | McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T Jr, Moeck G | J Antimicrob Chemother | 10.1093/jac/dkp126 | 2009 | |
| Phylogeny | Classification and antimicrobial susceptibilities of enterococcus species isolated from apparently healthy food-producing animals in Japan. | Kojima A, Morioka A, Kijima M, Ishihara K, Asai T, Fujisawa T, Tamura Y, Takahashi T | Zoonoses Public Health | 10.1111/j.1863-2378.2008.01204.x | 2009 | |
| Enzymology | A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. | Gu L, Cao B, Liu Y, Guo P, Song S, Li R, Dai H, Wang C | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2008.08.018 | 2009 | |
| Pathogenicity | Emergence and spread of vancomycin resistance among enterococci in Europe. | Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N | Euro Surveill | 2008 | | |
| Pathogenicity | Vancomycin resistance VanS/VanR two-component systems. | Hong HJ, Hutchings MI, Buttner MJ | Adv Exp Med Biol | 10.1007/978-0-387-78885-2_14 | 2008 | |
| Pathogenicity | Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran. | Emaneini M, Aligholi M, Aminshahi M | Pol J Microbiol | 2008 | | |
| Phylogeny | Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. | Libisch B, Lepsanovic Z, Top J, Muzslay M, Konkoly-Thege M, Gacs M, Balogh B, Fuzi M, Willems RJ | Scand J Infect Dis | 10.1080/00365540802165740 | 2008 | |
| Enzymology | Molecular characterization of enterococci harboring genotype and phenotype incongruence related to glycopeptide resistance isolated in Brazilian hospitals. | Henrique PM, Palazzo IC, Zanella RC, Darini AL | Mem Inst Oswaldo Cruz | 10.1590/s0074-02762008000300014 | 2008 | |
| Enzymology | Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. | Khan MA, van der Wal M, Farrell DJ, Cossins L, van Belkum A, Alaidan A, Hays JP | J Antimicrob Chemother | 10.1093/jac/dkn173 | 2008 | |
| Pathogenicity | In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative. | Draghi DC, Benton BM, Krause KM, Thornsberry C, Pillar C, Sahm DF | J Antimicrob Chemother | 10.1093/jac/dkn124 | 2008 | |
| Phylogeny | Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005. | Mlynarczyk G, Grzybowska W, Mlynarczyk A, Tyski S, Kawecki D, Luczak M, Chmura A, Rowinski W | Transplant Proc | 10.1016/j.transproceed.2007.08.045 | 2007 | |
| Pathogenicity | [Investigation of phenotypic and genotypic characteristics of vancomycin-resistant Enterococcus faecium isolates]. | Aktas Z, Diyarbakirli P, Bal C, Gurler N, Keser M, Somer A, Salman N | Mikrobiyol Bul | 2007 | | |
| Pathogenicity | Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. | Schmidt-Hieber M, Blau IW, Schwartz S, Uharek L, Weist K, Eckmanns T, Jonas D, Ruden H, Thiel E, Brandt C | Int J Hematol | 10.1532/IJH97.E0632 | 2007 | |
| Pathogenicity | The first molecular analysis of clinical isolates of VanA-type vancomycin-resistant Enterococcus faecium strains in Mainland China. | Zheng B, Tomita H, Xiao YH, Ike Y | Lett Appl Microbiol | 10.1111/j.1472-765X.2007.02191.x | 2007 | |
| Pathogenicity | Molecular characterization of vancomycin-resistant enterococcus faecium isolates from mainland China. | Zheng B, Tomita H, Xiao YH, Wang S, Li Y, Ike Y | J Clin Microbiol | 10.1128/JCM.00457-07 | 2007 | |
| Pathogenicity | Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. | Garcia-Migura L, Liebana E, Jensen LB | J Antimicrob Chemother | 10.1093/jac/dkm186 | 2007 | |
| Pathogenicity | Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. | Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2006.12.022 | 2007 | |
| Phylogeny | VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. | Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, Guaglianone E, Sundsfjord A, Pruzzo C, Donelli G, Facinelli B | Appl Environ Microbiol | 10.1128/AEM.02239-06 | 2007 | |
| Pathogenicity | [Molecular analysis of vancomycin-resistant enterococci isolated from clinical samples]. | Kilic A, Senses Z, Aydogan H, Basustaoglu A | Mikrobiyol Bul | 2006 | | |
| Phenotype | Case report vancomycin -resistant Enterococcus faecium VanA phenotype: first documented isolation in India. | Mohanty S, Dhawan B, Gadepalli RS, Lodha R, Kapil A | Southeast Asian J Trop Med Public Health | 2006 | | |
| Pathogenicity | Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. | Vouillamoz J, Moreillon P, Giddey M, Entenza JM | J Antimicrob Chemother | 10.1093/jac/dkl406 | 2006 | |
| Pathogenicity | Sources and pathways of spread of vancomycin-resistant enterococci in hemato-oncological patients. | Vagnerova I, Sauer P, Kolar M, Slepickova S, Hubacek J, Faber E, Raida L, Papajik T | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | 10.5507/bp.2006.017 | 2006 | |
| Pathogenicity | Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. | Kolar M, Pantucek R, Vagnerova I, Sauer P, Kesselova M, Cekanova L, Koukalova D, Doskar J, Ruzickova V | New Microbiol | 2006 | | |
| Transcriptome | Sequence analysis of Enterococcus faecium strain 10/96A (VanD4), the original vancomycin-resistant E. faecium strain in Brazil. | Camargo IL, Dalla Costa LM, Woodford N, Gilmore MS, Darini AL | J Clin Microbiol | 10.1128/JCM.00509-06 | 2006 | |
| Phylogeny | Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech Republic. | Kolar M, Pantucek R, Vagnerova I, Kesselova M, Sauer P, Matouskova I, Doskar J, Koukalova D, Hejnar P | Clin Microbiol Infect | 10.1111/j.1469-0691.2006.01365.x | 2006 | |
| Pathogenicity | Clinical glycopeptide-resistant enterococci isolated from patients after solid organ transplantation. | Sawicka-Grzelak A, Rokosz A, Przybylski M, Kawecki D, Krawczyk E, Rowinski W, Durlik M, Paczek L, Luczak M | Transplant Proc | 10.1016/j.transproceed.2005.11.095 | 2006 | |
| Pathogenicity | Comparative study of vanA gene transfer from Enterococcus faecium to Enterococcus faecalis and to Enterococcus faecium in the intestine of mice. | Bourgeois-Nicolaos N, Moubareck C, Mangeney N, Butel MJ, Doucet-Populaire F | FEMS Microbiol Lett | 10.1111/j.1574-6968.2005.00004.x | 2006 | |
| Phylogeny | Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. | Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, Borgmann S, Schulte B, Jonas D, Serr A, Fahr AM, Eigner U, Witte W | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-005-0056-0 | 2005 | |
| Pathogenicity | High prevalence of VanA-type vancomycin-resistant Enterococci in Austrian poultry. | Eisner A, Feierl G, Gorkiewicz G, Dieber F, Kessler HH, Marth E, Kofer J | Appl Environ Microbiol | 10.1128/AEM.71.10.6407-6409.2005 | 2005 | |
| Pathogenicity | [Pathogenic characters of infected bacteria after liver transplantation]. | Zhou JD, Zhu SH, Chen Y, Nie XM, Peng HY, Cheng K | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2005 | | |
| Pathogenicity | Occurrence of vancomycin-resistant enterococci in humans and animals in the Czech Republic between 2002 and 2004. | Kolar M, Pantucek R, Bardon J, Cekanova L, Kesselova M, Sauer P, Vagnerova I, Koukalova D | J Med Microbiol | 10.1099/jmm.0.45824-0 | 2005 | |
| Pathogenicity | Community-acquired vancomycin-resistant Enterococcus faecium: a case report from Malaysia. | Raja NS, Karunakaran R, Ngeow YF, Awang R | J Med Microbiol | 10.1099/jmm.0.46169-0 | 2005 | |
| Genetics | First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. | Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P | J Clin Microbiol | 10.1128/JCM.43.8.3642-3649.2005 | 2005 | |
| Pathogenicity | [Prevalence of vancomycin-resistant enterococci in hospital and community environment.]. | Kolar M, Pantucek R, Vagnerova I, Cekanova L, Kesselova M, Sauer P, Koukalova D, Kolar V, Ruzi kova M, Dosar J | Klin Mikrobiol Infekc Lek | 2005 | | |
| Pathogenicity | Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. | Ko KS, Baek JY, Lee JY, Oh WS, Peck KR, Lee N, Lee WG, Lee K, Song JH | J Clin Microbiol | 10.1128/JCM.43.5.2303-2306.2005 | 2005 | |
| Pathogenicity | Occurrence of insertion sequences within the genomes and Tn1546-like elements of glycopeptide-resistant enterococci isolated in Brazil, and identification of a novel element, ISEfa5. | Camargo IL, Zanella RC, Brandileone MC, Pignatari AC, Goldman GH, Woodford N, Darini AL | Int J Med Microbiol | 10.1016/j.ijmm.2004.11.003 | 2005 | |
| Pathogenicity | Identification of an unusual VanA element in glycopeptide-resistant Enterococcus faecium in Brazil following international transfer of a bone marrow transplant patient. | Camargo IL, Del Peloso PF, Da Costa Leite CF, Goldman GH, Darini AL | Can J Microbiol | 10.1139/w04-054 | 2004 | |
| Pathogenicity | Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods. | Kobayashi I, Muraoka H, Iyoda T, Nishida M, Hasegawa M, Yamaguchi K | J Med Microbiol | 10.1099/jmm.0.45765-0 | 2004 | |
| Pathogenicity | [The frequency of resistance to antibiotics of most frequently isolated bacteria from blood cultures during the period 1997-2002]. | Mirovic V, Tomanovic B, Konstantinovic S | Vojnosanit Pregl | 10.2298/vsp0404391m | 2004 | |
| Pathogenicity | The emergence of glycopeptide-resistant Enterococcus faecium in a university hospital in southwestern Greece. | Kolonitsiou F, Mani V, Parikou H, Trakala M, Dimitracopoulos G, Spiliopoulou I | Chemotherapy | 10.1159/000081945 | 2004 | |
| Pathogenicity | Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation. | Christidou A, Gikas A, Scoulica E, Pediaditis J, Roumbelaki M, Georgiladakis A, Tselentis Y | Clin Microbiol Infect | 10.1111/j.1469-0691.2004.00992.x | 2004 | |
| Pathogenicity | Two episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unit. | Borgmann S, Niklas DM, Klare I, Zabel LT, Buchenau P, Autenrieth IB, Heeg P | Int J Hyg Environ Health | 10.1078/1438-4639-00304 | 2004 | |
| Pathogenicity | Clonal dissemination of VanA-type glycopeptide-resistant Enterococcus faecalis between hospitals of two cities located 100 km apart. | Moretti ML, Bratfich OJ, Stucchi RB, Levi C, Levin AS, Duboc GM, Vormittag E, Blum-Menezes D | Braz J Med Biol Res | 10.1590/s0100-879x2004000900008 | 2004 | |
| Enzymology | Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. | Huh JY, Lee WG, Lee K, Shin WS, Yoo JH | J Clin Microbiol | 10.1128/JCM.42.5.1897-1902.2004 | 2004 | |
| Phylogeny | Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material. | Novicki TJ, Schapiro JM, Ulness BK, Sebeste A, Busse-Johnston L, Swanson KM, Swanzy SR, Leisenring W, Limaye AP | J Clin Microbiol | 10.1128/JCM.42.4.1637-1640.2004 | 2004 | |
| Pathogenicity | Highly conjugative pMG1-like plasmids carrying Tn1546-like transposons that encode vancomycin resistance in Enterococcus faecium. | Tomita H, Tanimoto K, Hayakawa S, Morinaga K, Ezaki K, Oshima H, Ike Y | J Bacteriol | 10.1128/JB.185.23.7024-7028.2003 | 2003 | |
| Pathogenicity | Occurrence and spread of antibiotic resistances in Enterococcus faecium. | Klare I, Konstabel C, Badstubner D, Werner G, Witte W | Int J Food Microbiol | 10.1016/s0168-1605(03)00190-9 | 2003 | |
| Pathogenicity | Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). | Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ | J Antimicrob Chemother | 10.1093/jac/dkg352 | 2003 | |
| Genetics | Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. | Campanile F, Bartoloni A, Bartalesi F, Borbone S, Mangani V, Mantella A, Nicoletti G, Paradisi F, Russo G, Strohmeyer M, Stefani S | Microb Drug Resist | 10.1089/107662903765826796 | 2003 | |
| Pathogenicity | European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. | Goossens H, Jabes D, Rossi R, Lammens C, Privitera G, Courvalin P | J Antimicrob Chemother | 10.1093/jac/dkg271 | 2003 | |
| Pathogenicity | Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). | Mutnick AH, Biedenbach DJ, Jones RN | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(03)00012-9 | 2003 | |
| Pathogenicity | Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue. | Ahrendt KA, Olsen JA, Wakao M, Trias J, Ellman JA | Bioorg Med Chem Lett | 10.1016/s0960-894x(03)00243-9 | 2003 | |
| Pathogenicity | Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. | Shin JW, Yong D, Kim MS, Chang KH, Lee K, Kim JM, Chong Y | J Infect Chemother | 10.1007/s10156-002-0215-5 | 2003 | |
| Pathogenicity | [Detection of vancomycin-resistant Enterococcus faecium: 2 years' experience in a high complexity hospital ]. | Lopreto CR, Viegas Caetano JA, Padlog R, Sorgentini M, Bardi C, Silvestri C | Rev Argent Microbiol | 2002 | | |
| Pathogenicity | Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center. | Rodriguez JL, Vazquez GJ, Bermudez M, De Orbeta J, Garcia Y, Rivera Y, Robledo IE | P R Health Sci J | 2002 | | |
| Pathogenicity | Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model. | Nannini EC, Pai SR, Singh KV, Murray BE | Antimicrob Agents Chemother | 10.1128/AAC.47.2.529-532.2003 | 2003 | |
| Pathogenicity | A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand. | Manson JM, Keis S, Smith JM, Cook GM | Antimicrob Agents Chemother | 10.1128/AAC.47.1.204-210.2003 | 2003 | |
| Pathogenicity | [Antibiotic resistance in hospital strains of Enterococcus faecalis and Enterococcus faecium]. | Mirovic V | Vojnosanit Pregl | 10.2298/vsp0205499m | 2002 | |
| Pathogenicity | Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. | Johnsen PJ, Simonsen GS, Olsvik O, Midtvedt T, Sundsfjord A | Microb Drug Resist | 10.1089/107662902760326869 | 2002 | |
| Enzymology | First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. | Colak D, Naas T, Gunseren F, Fortineau N, Ogunc D, Gultekin M, Nordmann P | J Antimicrob Chemother | 10.1093/jac/dkf134 | 2002 | |
| Cultivation | Possible connection between a widely disseminated conjugative gentamicin resistance (pMG1-like) plasmid and the emergence of vancomycin resistance in Enterococcus faecium. | Tomita H, Pierson C, Lim SK, Clewell DB, Ike Y | J Clin Microbiol | 10.1128/JCM.40.9.3326-3333.2002 | 2002 | |
| Enzymology | First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. | Panesso D, Ospina S, Robledo J, Vela MC, Pena J, Hernandez O, Reyes J, Arias CA | Emerg Infect Dis | 10.3201/eid0809.010435 | 2002 | |
| Pathogenicity | The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use. | Kolar M, Vagnerova I, Latal T, Urbanek K, Typovska H, Hubacek J, Papajik T, Raida L, Faber E | New Microbiol | 2002 | | |
| Identification of enterococci and determination of their glycopeptide resistance in German and Austrian clinical microbiology laboratories. | Klare I, Badstubner D, Konstabel C, Witte W | Clin Microbiol Infect | 10.1111/j.1469-0691.1999.tb00431.x | 1999 | | |
| Pathogenicity | Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci. | Shigei J, Tan G, Shiao A, de la Maza LM, Peterson EM | Am J Clin Pathol | 10.1309/TWY5-04QE-9KV0-52MT | 2002 | |
| Pathogenicity | Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. | Woodford N | Microb Drug Resist | 10.1089/10766290152652774 | 2001 | |
| Metabolism | The VanY(D) DD-carboxypeptidase of Enterococcus faecium BM4339 is a penicillin-binding protein. | Reynolds PE, Ambur OH, Casadewall B, Courvalin P | Microbiology (Reading) | 10.1099/00221287-147-9-2571 | 2001 | |
| Genetics | Characterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. | Demertzi E, Palepou MI, Kaufmann ME, Avlamis A, Woodford N | J Med Microbiol | 10.1099/0022-1317-50-8-682 | 2001 | |
| Pathogenicity | Recovery from a single blood culture of two enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. | Biavasco F, Paladini C, Vignaroli C, Foglia G, Manso E, Varaldo PE | Eur J Clin Microbiol Infect Dis | 10.1007/pl00011270 | 2001 | |
| Pathogenicity | Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model. | Rupp ME, Fey PD, Longo GM | J Antimicrob Chemother | 10.1093/jac/47.5.705 | 2001 | |
| Pathogenicity | In-vitro activity of fosfomycin against vancomycin-resistant enterococci. | Allerberger F, Klare I | J Antimicrob Chemother | 10.1093/jac/43.2.211 | 1999 | |
| Phylogeny | Vancomycin-resistant Enterococcus faecium strain carrying the vanB2 gene variant in a Polish hospital. | Kawalec M, Gniadkowski M, Zielinska U, Klos W, Hryniewicz W | J Clin Microbiol | 10.1128/JCM.39.2.811-815.2001 | 2001 | |
| Pathogenicity | Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiologic features. | Carretto E, Barbarini D, Locatelli F, Giraldi E, Pellegrini N, Perversi L, Grossi P, Marone P, Bonetti F | Haematologica | 2000 | | |
| Pathogenicity | Impact of flavophospholipol and vancomycin on conjugational transfer of vancomycin resistance plasmids. | Riedl S, Ohlsen K, Werner G, Witte W, Hacker J | Antimicrob Agents Chemother | 10.1128/AAC.44.11.3189-3192.2000 | 2000 | |
| Enzymology | Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains. | Kawalec M, Gniadkowski M, Hryniewicz W | J Clin Microbiol | 10.1128/JCM.38.9.3317-3322.2000 | 2000 | |
| Enzymology | Genotypic characterisation of endemic VanA Enterococcus faecium strains isolated in a paediatric hospital. | Barnaud G, Bingen E | J Med Microbiol | 10.1099/0022-1317-49-9-793 | 2000 | |
| Pathogenicity | Problems and perils of vancomycin resistant enterococci. | Murray BE | Braz J Infect Dis | 2000 | | |
| Pathogenicity | PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium. | Donabedian S, Hershberger E, Thal LA, Chow JW, Clewell DB, Robinson-Dunn B, Zervos MJ | J Clin Microbiol | 10.1128/JCM.38.8.2885-2888.2000 | 2000 | |
| Pathogenicity | The molecular basis of vancomycin resistance in clinically relevant Enterococci: crystal structure of D-alanyl-D-lactate ligase (VanA). | Roper DI, Huyton T, Vagin A, Dodson G | Proc Natl Acad Sci U S A | 10.1073/pnas.150116497 | 2000 | |
| Pathogenicity | Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. | Simonsen GS, Myhre MR, Dahl KH, Olsvik O, Sundsfjord A | Microb Drug Resist | 10.1089/mdr.2000.6.49 | 2000 | |
| Pathogenicity | Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. | Nelson RR, McGregor KF, Brown AR, Amyes SG, Young H | J Clin Microbiol | 10.1128/JCM.38.6.2112-2116.2000 | 2000 | |
| Phylogeny | Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. | Garcia-Garrote F, Cercenado E, Bouza E | J Clin Microbiol | 10.1128/JCM.38.6.2108-2111.2000 | 2000 | |
| Genetics | Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium. | Darini AL, Palepou MF, Woodford N | Antimicrob Agents Chemother | 10.1128/AAC.44.5.1362-1364.2000 | 2000 | |
| Pathogenicity | Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. | Nourse C, Byrne C, Murphy H, Kaufmann ME, Clarke A, Butler K | Epidemiol Infect | 10.1017/s095026889900326x | 2000 | |
| Pathogenicity | A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. | Ostrowsky BE, Clark NC, Thauvin-Eliopoulos C, Venkataraman L, Samore MH, Tenover FC, Eliopoulos GM, Moellering RC Jr, Gold HS | J Infect Dis | 10.1086/315030 | 1999 | |
| Phenotype | First confirmed case of a vancomycin-resistant Enterococcus faecium with vanA phenotype from Brazil: isolation from a meningitis case in Sao Paulo. | Zanella RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SC, Vieira VS, Brandileone MC | Microb Drug Resist | 10.1089/mdr.1999.5.159 | 1999 | |
| Enzymology | Crystallization and preliminary X-ray characterization of VanA from Enterococcus faecium BM4147: towards the molecular basis of bacterial resistance to the glycopeptide antibiotic vancomycin. | Huyton T, Roper DI | Acta Crystallogr D Biol Crystallogr | 10.1107/s0907444999007155 | 1999 | |
| Genetics | Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. | Casadewall B, Courvalin P | J Bacteriol | 10.1128/JB.181.12.3644-3648.1999 | 1999 | |
| Pathogenicity | Nucleotide sequence of IS1542, an insertion sequence identified within VanA glycopeptide resistance elements of enterococci. | Darini AL, Palepou MF, Woodford N | FEMS Microbiol Lett | 10.1111/j.1574-6968.1999.tb13523.x | 1999 | |
| Pathogenicity | Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. | Simonsen GS, Andersen BM, Digranes A, Harthug S, Jacobsen T, Lingaas E, Natas OB, Olsvik O, Ringertz SH, Skulberg A, Syversen G, Sundsfjord A | Scand J Infect Dis | 10.1080/00365549850161449 | 1998 | |
| Phylogeny | Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland. | Samet A, Bronk M, Hellmann A, Kur J | J Hosp Infect | 10.1016/s0195-6701(99)90051-8 | 1999 | |
| Pathogenicity | Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. | Simonsen GS, Haaheim H, Dahl KH, Kruse H, Lovseth A, Olsvik O, Sundsfjord A | Microb Drug Resist | 10.1089/mdr.1998.4.313 | 1998 | |
| Enzymology | The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. | Kim WJ, Weinstein RA, Hayden MK | J Infect Dis | 10.1086/314564 | 1999 | |
| Enzymology | Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. | Brown AR, Amyes SG, Paton R, Plant WD, Stevenson GM, Winney RJ, Miles RS | J Hosp Infect | 10.1016/s0195-6701(98)90090-1 | 1998 | |
| Pathogenicity | Glycopeptide-resistant enterococci: a decade of experience. | Woodford N | J Med Microbiol | 10.1099/00222615-47-10-849 | 1998 | |
| Pathogenicity | European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. | Felmingham D, Brown DF, Soussy CJ | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(98)00053-4 | 1998 | |
| Pathogenicity | Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. | Bell JM, Paton JC, Turnidge J | J Clin Microbiol | 10.1128/JCM.36.8.2187-2190.1998 | 1998 | |
| Pathogenicity | Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. | Eliopoulos GM, Wennersten CB, Gold HS, Schulin T, Souli M, Farris MG, Cerwinka S, Nadler HL, Dowzicky M, Talbot GH, Moellering RC Jr | Antimicrob Agents Chemother | 10.1128/AAC.42.5.1088 | 1998 | |
| Metabolism | Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. | Woodford N, Adebiyi AM, Palepou MF, Cookson BD | Antimicrob Agents Chemother | 10.1128/AAC.42.3.502 | 1998 | |
| Enzymology | Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. | Nourse C, Murphy H, Byrne C, O'Meara A, Breatnach F, Kaufmann M, Clarke A, Butler K | Eur J Pediatr | 10.1007/s004310050760 | 1998 | |
| Genetics | Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak. | Woodford N, Chadwick PR, Morrison D, Cookson BD | J Clin Microbiol | 10.1128/jcm.35.11.2966-2968.1997 | 1997 | |
| Genetics | VanD-type glycopeptide-resistant Enterococcus faecium BM4339. | Perichon B, Reynolds P, Courvalin P | Antimicrob Agents Chemother | 10.1128/AAC.41.9.2016 | 1997 | |
| Genetics | Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. | MacKinnon MG, Drebot MA, Tyrrell GJ | Antimicrob Agents Chemother | 10.1128/AAC.41.8.1805 | 1997 | |
| Pathogenicity | Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci. | Sahm DF, Free L, Smith C, Eveland M, Mundy LM | J Clin Microbiol | 10.1128/jcm.35.8.2026-2030.1997 | 1997 | |
| Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. | Boisivon A, Thibault M, Leclercq R | Clin Microbiol Infect | 10.1111/j.1469-0691.1997.tb00594.x | 1997 | | |
| Phylogeny | Comparison of agar-based media for primary isolation of glycopeptide-resistant enterococci. | Chadwick PR, Brown DF, Wilcox MH, Collyns TA, Walpole E, Dillon J, Smith R, Gopal Rao G, Oppenheim BA | Clin Microbiol Infect | 10.1111/j.1469-0691.1997.tb00308.x | 1997 | |
| Enzymology | Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. | Torell E, Fredlund H, Tornquist E, Myhre EB, Sjoberg L, Sundsfjord A | Scand J Infect Dis | 10.3109/00365549709019039 | 1997 | |
| Genetics | The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. | Arthur M, Depardieu F, Gerbaud G, Galimand M, Leclercq R, Courvalin P | J Bacteriol | 10.1128/jb.179.1.97-106.1997 | 1997 | |
| Pathogenicity | Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. | Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH | J Hosp Infect | 10.1016/s0195-6701(96)90063-8 | 1996 | |
| Pathogenicity | Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. | Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H | Antimicrob Agents Chemother | 10.1128/AAC.40.8.1938 | 1996 | |
| Metabolism | Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. | Arthur M, Depardieu F, Reynolds P, Courvalin P | Mol Microbiol | 10.1046/j.1365-2958.1996.00617.x | 1996 | |
| Pathogenicity | Vancomycin-resistant enterococci. | Gin AS, Zhanel GG | Ann Pharmacother | 10.1177/106002809603000610 | 1996 | |
| Genetics | Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid. | Heaton MP, Discotto LF, Pucci MJ, Handwerger S | Gene | 10.1016/0378-1119(96)00022-4 | 1996 | |
| Pathogenicity | In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. | Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ | Antimicrob Agents Chemother | 10.1128/AAC.40.4.839 | 1996 | |
| Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. | Moulin F, Dumontier S, Saulnier P, Chachaty E, Loubeyre C, Brugieres L, Andremont A | Clin Microbiol Infect | 10.1016/s1198-743x(14)65142-9 | 1996 | | |
| Metabolism | Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. | Ellsworth BA, Tom NJ, Bartlett PA | Chem Biol | 10.1016/s1074-5521(96)90082-4 | 1996 | |
| Pathogenicity | In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species. | Biavasco F, Giovanetti E, Miele A, Vignaroli C, Facinelli B, Varaldo PE | Eur J Clin Microbiol Infect Dis | 10.1007/BF01586185 | 1996 | |
| Pathogenicity | Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. | Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann G, Hakenbeck R, Antanassova V, Witte W | Microb Drug Resist | 10.1089/mdr.1995.1.265 | 1995 | |
| Pathogenicity | Conjugative mobilization of a vancomycin resistance plasmid by a putative Enterococcus faecium sex pheromone response plasmid. | Heaton MP, Handwerger S | Microb Drug Resist | 10.1089/mdr.1995.1.177 | 1995 | |
| Pathogenicity | In vitro activity of the semisynthetic glycopeptide amide MDL 63,246. | Kenny MT, Brackman MA, Dulworth JK | Antimicrob Agents Chemother | 10.1128/AAC.39.7.1589 | 1995 | |
| Genetics | Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. | Handwerger S, Skoble J, Discotto LF, Pucci MJ | Antimicrob Agents Chemother | 10.1128/AAC.39.2.362 | 1995 | |
| Enzymology | Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. | Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN | J Clin Microbiol | 10.1128/jcm.32.11.2840-2842.1994 | 1994 | |
| Pathogenicity | Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. | Bates J, Jordens JZ, Griffiths DT | J Antimicrob Chemother | 10.1093/jac/34.4.507 | 1994 | |
| Metabolism | Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. | Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P | Mol Microbiol | 10.1111/j.1365-2958.1994.tb00497.x | 1994 | |
| Genetics | vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. | Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F | J Antimicrob Chemother | 10.1093/jac/33.3.553 | 1994 | |
| Enzymology | Characterization of glycopeptide-resistant enterococci from U.S. hospitals. | Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC | Antimicrob Agents Chemother | 10.1128/AAC.37.11.2311 | 1993 | |
| Pathogenicity | Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. | Green M, Binczewski B, Pasculle AW, Edmund M, Barbadora K, Kusne S, Shlaes DM | Antimicrob Agents Chemother | 10.1128/AAC.37.6.1238 | 1993 | |
| Enzymology | In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. | Hayden MK, Trenholme GM, Schultz JE, Sahm DF | J Infect Dis | 10.1093/infdis/167.5.1224 | 1993 | |
| Pathogenicity | Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. | Fraimow HS, Venuti E | Antimicrob Agents Chemother | 10.1128/AAC.36.7.1563 | 1992 | |
| Pathogenicity | Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. | Wright GD, Molinas C, Arthur M, Courvalin P, Walsh CT | Antimicrob Agents Chemother | 10.1128/AAC.36.7.1514 | 1992 | |
| Enzymology | The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. | Arthur M, Molinas C, Courvalin P | J Bacteriol | 10.1128/jb.174.8.2582-2591.1992 | 1992 | |
| Metabolism | Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. | Arthur M, Molinas C, Bugg TD, Wright GD, Walsh CT, Courvalin P | Antimicrob Agents Chemother | 10.1128/AAC.36.4.867 | 1992 | |
| Pathogenicity | Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. | Handwerger S, Perlman DC, Altarac D, McAuliffe V | Clin Infect Dis | 10.1093/clinids/14.3.655 | 1992 | |
| Enzymology | Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. | Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT | Biochemistry | 10.1021/bi00107a007 | 1991 | |
| Enzymology | Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. | Bugg TD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT | Biochemistry | 10.1021/bi00222a002 | 1991 | |
| Pathogenicity | Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium. | Gargvanshi S, Gutheil WG | Microbiol Spectr | 10.1128/spectrum.01412-22 | 2022 | |
| Phylogeny | Streptomyces swartbergensis sp. nov., a novel tyrosinase and antibiotic producing actinobacterium. | le Roes-Hill M, Prins A, Meyers PR | Antonie Van Leeuwenhoek | 10.1007/s10482-017-0979-3 | 2017 | |
| Phylogeny | Streptomyces polyantibioticus sp. nov., isolated from the banks of a river. | le Roes-Hill M, Meyers PR | Int J Syst Evol Microbiol | 10.1099/ijs.0.006171-0 | 2009 | |
| Phylogeny | Actinomadura rudentiformis sp. nov., isolated from soil. | le Roes M, Meyers PR | Int J Syst Evol Microbiol | 10.1099/ijs.0.64438-0 | 2007 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive5300.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License